<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Explor Res Clin Soc Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Explor Res Clin Soc Pharm</journal-id><journal-title-group><journal-title>Exploratory Research in Clinical and Social Pharmacy</journal-title></journal-title-group><issn pub-type="epub">2667-2766</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12099458</article-id><article-id pub-id-type="pii">S2667-2766(25)00049-6</article-id><article-id pub-id-type="doi">10.1016/j.rcsop.2025.100608</article-id><article-id pub-id-type="publisher-id">100608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Multi-stakeholder perspective on community pharmacy services in Saudi Arabia: A systematic review and meta-analyses for 2010&#x02013;2020</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name><surname>Alghamdi</surname><given-names>Khalid S.</given-names></name><email>Khalid.alghamdi@gu.se</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="af0010" ref-type="aff">b</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="au0010"><name><surname>Petzold</surname><given-names>Max</given-names></name><email>max.petzold@gu.se</email><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0015"><name><surname>Alsugoor</surname><given-names>Mahdi H.</given-names></name><email>mhsugoor@uqu.edu.sa</email><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0020"><name><surname>Makeen</surname><given-names>Hafiz A.</given-names></name><email>hafiz@jazanu.edu.sa</email><xref rid="af0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au0025"><name><surname>Persson</surname><given-names>Christina Ljungberg</given-names></name><email>christina.ljungberg.persson@gu.se</email><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0030"><name><surname>Hussain-Alkhateeb</surname><given-names>Laith</given-names></name><email>laith.hussain@gu.se</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="af0025" ref-type="aff">e</xref></contrib><aff id="af0005"><label>a</label>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Box 469, 40530 G&#x000f6;teborg, Sweden</aff><aff id="af0010"><label>b</label>Department of Clinical Pharmacy, Faculty of Pharmacy, Al Baha University, Al Baha, Saudi Arabia</aff><aff id="af0015"><label>c</label>Department of Emergency Medical Services, Faculty of Health Sciences, Al-Qunfudah, Umm Al-Qura University, 21912 Makkah, Saudi Arabia</aff><aff id="af0020"><label>d</label>Department of Clinical Pharmacy, Faculty of Pharmacy, Jazan University, 6809 Jazan, Saudi Arabia</aff><aff id="af0025"><label>e</label>Department of Population Health, King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author at: School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Box 469, 40530 G&#x000f6;teborg, Sweden. <email>Khalid.alghamdi@gu.se</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>28</day><month>4</month><year>2025</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>4</month><year>2025</year></pub-date><volume>18</volume><elocation-id>100608</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>8</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="ab0005"><sec><title>Background</title><p>Community pharmacists are the third-largest group of healthcare professionals globally; their capacity often extends far beyond dispensing medication, and they are increasingly involved in a diverse range of advanced health service delivery, which can potentially improve public health outcomes. Among the many initiatives of the Saudi national transformation program towards Saudi Vision 2030 are plans to transform the current model of community pharmacy services by expanding their role to include patient-centered healthcare provision.</p></sec><sec><title>Objectives</title><p>This systematic literature review (2010&#x02212;2020) of the multi-stakeholder perspective aimed to evaluate services provided by Saudi community pharmacies and satisfaction levels, investigate perceived factors associated with the practice, and identify barriers affecting services.</p></sec><sec><title>Materials and methods</title><p>Seven scientific electronic databases were searched. The review was conducted in accordance with PRISMA guidelines. This review was subjected to descriptive analyses, meta-analyses of proportion, and narrative synthesis. The Mixed Methods Appraisal Tool version 2018 was used to assess the quality of studies.</p></sec><sec><title>Results</title><p>Minimal physician participation, community pharmacies' owners and managers, and gender imbalance among pharmacists all arose as gaps in Saudi Arabia. The findings showed that community pharmacies enable self-medication, with one-third of antibiotics being dispensed without prescriptions despite the threat of law enforcement. The deficiency of patient counseling by community pharmacists threatens patient safety, and the lack of knowledge about clinical services diminishes opportunities for adequate practice.</p></sec><sec><title>Conclusion</title><p>Several factors contributing to this inadequate performance and low satisfaction levels were reported. The findings were alarming and highlighted the need to intensify efforts towards Saudi Vision 2030, which aims to improve the overall population health and healthcare system in Saudi Arabia. Our review suggests that more efforts are needed to integrate key commercial, administrative, and technical sectors associated with the processes of community pharmacy dispensing and counseling.</p></sec></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>Community pharmacy</kwd><kwd>Pharmacy practice</kwd><kwd>Services</kwd><kwd>Barriers</kwd><kwd>Saudi Arabia</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0005">Globally, community pharmacists are the third-largest group of healthcare professionals, behind only physicians and nurses.<xref rid="bb0005" ref-type="bibr"><sup>1</sup></xref> Their role extends far beyond dispensing medication: due to a rapid evolution of the healthcare system, community pharmacists are involved in a diverse range of advanced health service delivery. This evolution can potentially improve pharmaceutical care delivery, offering a positive outlook for the profession's future.<xref rid="bb0010" ref-type="bibr"><sup>2</sup></xref> The emerging community pharmacy (CP) model, conceived in industrialized countries, visualizes patient-centered service providers<xref rid="bb0015" ref-type="bibr"><sup>3</sup></xref> for services including public health screenings, medicine use reviews, and flu vaccination. These advanced services require a high level of clinical, research, and educational competence in community pharmacists.<xref rid="bb0020" ref-type="bibr"><sup>4</sup></xref></p><p id="p0010">However, the services offered by CPs in developing countries are generally limited and tend to be associated with unique and often challenging sets of circumstances.<xref rid="bb0025" ref-type="bibr"><sup>5</sup></xref> The traditional view of CPs as intermediaries between physicians and patients means that patient-centered and advanced professional services are not fully implemented alongside traditional, product-centered services.<xref rid="bb0030" ref-type="bibr"><sup>6</sup></xref> Nevertheless, public health officials share an understanding of the need to expand the role of CPs in healthcare delivery. Such an expansion could potentially improve medication adherence, reduce hospitalizations, and bolster primary care health services, particularly in managing chronic diseases.<xref rid="bb0035" ref-type="bibr"><sup>7</sup></xref></p><p id="p0015">In Saudi Arabia (SA), 23,649 community pharmacists work in 10,347 independent and chain CPs.<xref rid="bb0040" ref-type="bibr"><sup>8</sup></xref> Of them, 18,967 are expatriates, and 4682 are Saudi citizens.<xref rid="bb0040" ref-type="bibr"><sup>8</sup></xref> Regarding the profession, CPs are mainly regulated by three official authorities. The Saudi Ministry Of Health (MOH) is responsible for issuing and updating the national drug formulary, granting licenses to establish a CP premise, and releasing legislation and policies.<xref rid="bb0045" ref-type="bibr"><sup>9</sup></xref> The Saudi Food and Drug Authority is responsible for the safety of medicines and electronic health devices, including registration and price.<xref rid="bb0050" ref-type="bibr"><sup>10</sup></xref> The Saudi Commission of Health Specialties handles the registration and classification of healthcare-related practices, including pharmacists, enabling them to practice the profession.<xref rid="bb0055" ref-type="bibr"><sup>11</sup></xref></p><p id="p0020">However, implementing advanced patient-centered CP services, including relevant legal aspects, is underway.<xref rid="bb0060" ref-type="bibr">12</xref>, <xref rid="bb0065" ref-type="bibr">13</xref>, <xref rid="bb0070" ref-type="bibr">14</xref> At the same time, the CP sector is dominated by expatriate community pharmacists,<xref rid="bb0040" ref-type="bibr"><sup>8</sup></xref> which may lead to language and cultural miscommunications, affecting CPs' practice in the highly diverse Saudi population. Since its inception in 2016, Saudi Vision 2030 and the National Transformation Program have been instrumental in shaping the country's future. The vision is based on economic, social, and cultural pillars. The National Transformation program includes numerous initiatives aimed at transforming the current model of CP services<xref rid="bb0075" ref-type="bibr"><sup>15</sup></xref> by expanding community pharmacists' role to include patient-centered healthcare provision.<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref> Moreover, this program also contains a proposal to transfer all outpatient pharmacy services from the public sector to CPs.<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref> Therefore, in 2018, one key initiative is to start digitizing data and launch an electronic prescription platform (Wasfaty) so patients can receive their medication for free from optional CPs. This advanced digital, dynamic, and regulated platform ensures reduced or averted medication errors, drug-drug interactions, and duplicate dispensing. It also helps direct communication between community pharmacists and physicians.<xref rid="bb0085" ref-type="bibr"><sup>17</sup></xref></p><p id="p0025">To this end, understanding the multiple stakeholders' views is essential to the health system transformation: relevant stakeholders from multiple sectors can contribute to the evidence base for Saudi CP services and the know-how of good pharmacy practices in line with Saudi Vision 2030. The current systematic review and meta-analyses aimed to identify all empirical research studies published between 2010 and 2020 in SA on CP services, which took the perspectives of multiple stakeholders, including CP users, community pharmacists, physicians, academics, and policymakers. This review specifically evaluated the services provided by community pharmacies and the satisfaction levels with those services, and it investigated any perceived barriers affecting their practice.</p></sec><sec id="s0010"><label>2</label><title>Materials and methods</title><sec id="s0015"><label>2.1</label><title>Protocol and registration</title><p id="p0030">This systematic review was guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA, 2020) guidelines, found in <xref rid="ec0005" ref-type="supplementary-material">supplementary material 1</xref>. A review protocol for this review was published on the international Prospective Register of Systematic Reviews (PROSPERO), registration number #CRD42020202653, on September 4, 2020.</p></sec><sec id="s0020"><label>2.2</label><title>Search terms and strategy</title><p id="p0040">The Setting, Population, Intervention, Comparison, and Evaluation (SPICE) conceptual framework was proposed to determine the search terms for this review.<xref rid="bb0090" ref-type="bibr"><sup>18</sup></xref> (see <xref rid="t0005" ref-type="table">Table 1</xref>, <xref rid="ec0010" ref-type="supplementary-material">Supplementary Material 2</xref>). This systematic review had eight categories of inclusion and exclusion criteria: type of published articles, participants, setting, location, study design, the language of published articles, publication date, and type of access to databases. Further details regarding the inclusion and exclusion criteria can be found in <xref rid="t0010" ref-type="table">Table 2</xref> of <xref rid="ec0010" ref-type="supplementary-material">Supplementary Material 2</xref>. Search terms were identified by all reviewers using medical subject headings (MeSH) in PubMed and thereafter applied to all other compatible database searches. Seven scientific electronic databases were searched: CINAHL, Cochrane Library, Ovid, Google Scholar, PubMed, Scopus, and Web of Science. Each database search was subjected to specific search options and restrictions based on inclusion criteria (<xref rid="t0015" ref-type="table">Table 3</xref>, <xref rid="ec0010" ref-type="supplementary-material">Supplementary Material 2</xref>), and Boolean search techniques combined keywords by the operators &#x02018;OR&#x02019; and &#x02018;AND&#x02019;. A pilot search was applied to evaluate each database's initial identification of relevant studies. An alert notification was established in all databases for any newly published studies which matched the inclusion criteria. The search of all combined terms and keywords is provided in <xref rid="t0020" ref-type="table">Table 4</xref>, <xref rid="ec0010" ref-type="supplementary-material">Supplementary Material 2</xref>.</p></sec><sec id="s0025"><label>2.3</label><title>Selection processes</title><p id="p0050">The selection process began by identifying studies, followed by a screening process. The identification process was conducted in two phases: in Phase I, studies which met all inclusion criteria were identified, saved, and exported into the EndNote reference manager,<xref rid="bb0095" ref-type="bibr"><sup>19</sup></xref> and duplicate records were removed; in Phase II, studies were identified through citation searching of the included studies in Phase I. Studies identified in both phases were subjected to the screening process, which was conducted in two phases. In Phase I, the titles and abstracts of the identified studies were screened, and irrelevant studies were excluded. Each study's references were screened in order to identify studies through citation searching, and any title which included &#x0201c;Saudi&#x0201d; as a keyword was subjected to the screening process. In Phase II, the full texts of the remaining studies were assessed for eligibility, and records which did not match the inclusion criteria were excluded. The principal author (KA) conducted the selection process, and a second review author (MH) cross-checked the selection process following the same eligibility criteria; any disagreement was resolved by discussion or, where necessary, with the help of a third author (LH).<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>Characteristics of included studies (<italic>n</italic>&#x000a0;=&#x000a0;89).</p></caption><alt-text id="al0010">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Characteristics of included studies</th><th align="center">Frequency</th><th align="center">%</th></tr></thead><tbody><tr><td><bold>Type of stakeholders</bold></td><td/><td/></tr><tr><td>&#x000a0;Community pharmacists<xref rid="bb0130" ref-type="bibr">26</xref>, <xref rid="bb0135" ref-type="bibr">27</xref>, <xref rid="bb0140" ref-type="bibr">28</xref>, <xref rid="bb0145" ref-type="bibr">29</xref>, <xref rid="bb0150" ref-type="bibr">30</xref>, <xref rid="bb0155" ref-type="bibr">31</xref>, <xref rid="bb0160" ref-type="bibr">32</xref>, <xref rid="bb0165" ref-type="bibr">33</xref>, <xref rid="bb0170" ref-type="bibr">34.</xref>, <xref rid="bb0175" ref-type="bibr">35</xref>, <xref rid="bb0180" ref-type="bibr">36</xref>, <xref rid="bb0185" ref-type="bibr">37</xref>, <xref rid="bb0190" ref-type="bibr">38</xref>, <xref rid="bb0195" ref-type="bibr">39</xref>, <xref rid="bb0200" ref-type="bibr">40</xref>, <xref rid="bb0205" ref-type="bibr">41</xref>, <xref rid="bb0210" ref-type="bibr">42</xref>, <xref rid="bb0215" ref-type="bibr">43</xref>, <xref rid="bb0220" ref-type="bibr">44</xref>, <xref rid="bb0225" ref-type="bibr">45</xref>, <xref rid="bb0230" ref-type="bibr">46</xref>, <xref rid="bb0235" ref-type="bibr">47</xref>, <xref rid="bb0240" ref-type="bibr">48</xref>, <xref rid="bb0245" ref-type="bibr">49</xref>, <xref rid="bb0250" ref-type="bibr">50</xref>, <xref rid="bb0255" ref-type="bibr">51</xref>, <xref rid="bb0260" ref-type="bibr">52</xref>, <xref rid="bb0265" ref-type="bibr">53</xref>, <xref rid="bb0270" ref-type="bibr">54</xref>, <xref rid="bb0275" ref-type="bibr">55</xref>, <xref rid="bb0280" ref-type="bibr">56</xref>, <xref rid="bb0285" ref-type="bibr">57</xref>, <xref rid="bb0290" ref-type="bibr">58</xref>, <xref rid="bb0295" ref-type="bibr">59</xref>, <xref rid="bb0300" ref-type="bibr">60</xref>, <xref rid="bb0305" ref-type="bibr">61</xref>, <xref rid="bb0310" ref-type="bibr">62</xref>, <xref rid="bb0315" ref-type="bibr">63</xref>, <xref rid="bb0320" ref-type="bibr">64</xref>, <xref rid="bb0325" ref-type="bibr">65</xref>, <xref rid="bb0330" ref-type="bibr">66</xref>, <xref rid="bb0335" ref-type="bibr">67</xref>, <xref rid="bb0340" ref-type="bibr">68</xref>, <xref rid="bb0345" ref-type="bibr">69</xref>, <xref rid="bb0350" ref-type="bibr">70</xref>, <xref rid="bb0355" ref-type="bibr">71</xref>, <xref rid="bb0360" ref-type="bibr">72</xref>, <xref rid="bb0365" ref-type="bibr">73</xref>, <xref rid="bb0370" ref-type="bibr">74</xref>, <xref rid="bb0375" ref-type="bibr">75</xref>, <xref rid="bb0380" ref-type="bibr">76</xref>, <xref rid="bb0385" ref-type="bibr">77</xref>, <xref rid="bb0390" ref-type="bibr">78</xref>, <xref rid="bb0395" ref-type="bibr">79</xref>, <xref rid="bb0400" ref-type="bibr">80</xref>, <xref rid="bb0405" ref-type="bibr">81</xref>, <xref rid="bb0410" ref-type="bibr">82.</xref>, <xref rid="bb0415" ref-type="bibr">83</xref>, <xref rid="bb0420" ref-type="bibr">84</xref>, <xref rid="bb0425" ref-type="bibr">85</xref>, <xref rid="bb0430" ref-type="bibr">86</xref>, <xref rid="bb0435" ref-type="bibr">87</xref>, <xref rid="bb0440" ref-type="bibr">88</xref>, <xref rid="bb0445" ref-type="bibr">89</xref>, <xref rid="bb0450" ref-type="bibr">90</xref>, <xref rid="bb0455" ref-type="bibr">91</xref>, <xref rid="bb0460" ref-type="bibr">92</xref>, <xref rid="bb0465" ref-type="bibr">93</xref></td><td align="center">68</td><td align="center">76.40&#x000a0;%</td></tr><tr><td>&#x000a0;Patients or customers<xref rid="bb0470" ref-type="bibr">94</xref>, <xref rid="bb0475" ref-type="bibr">95</xref>, <xref rid="bb0480" ref-type="bibr">96</xref>, <xref rid="bb0485" ref-type="bibr">97</xref>, <xref rid="bb0490" ref-type="bibr">98</xref>, <xref rid="bb0495" ref-type="bibr">99</xref>, <xref rid="bb0500" ref-type="bibr">100</xref>, <xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref>, <xref rid="bb0515" ref-type="bibr">103</xref>, <xref rid="bb0520" ref-type="bibr">104</xref>, <xref rid="bb0525" ref-type="bibr">105</xref>, <xref rid="bb0530" ref-type="bibr">106</xref>, <xref rid="bb0535" ref-type="bibr">107</xref>, <xref rid="bb0540" ref-type="bibr">108</xref>, <xref rid="bb0545" ref-type="bibr">109</xref></td><td align="center">16</td><td align="center">17.80&#x000a0;%</td></tr><tr><td>&#x000a0;Multiple stakeholders<xref rid="bb0060" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="bb0550" ref-type="bibr">110</xref>, <xref rid="bb0555" ref-type="bibr">111</xref>, <xref rid="bb0560" ref-type="bibr">112</xref>, <xref rid="bb0565" ref-type="bibr">113</xref></td><td align="center">5</td><td align="center">5.60&#x000a0;%</td></tr><tr><td><bold>Type of research design</bold></td><td/><td/></tr><tr><td>&#x000a0;Quantitative approach</td><td align="center">75</td><td align="center">84.30&#x000a0;%</td></tr><tr><td>&#x000a0;Cross-sectional surveys</td><td align="center">59</td><td align="center">66.30&#x000a0;%</td></tr><tr><td>&#x000a0;Simulated patient visits</td><td align="center">17</td><td align="center">19.10&#x000a0;%</td></tr><tr><td>&#x000a0;Qualitative approach (interviews)</td><td align="center">12</td><td align="center">13.50&#x000a0;%</td></tr><tr><td>&#x000a0;Mixed-method approach</td><td align="center">2</td><td align="center">2.20&#x000a0;%</td></tr><tr><td><bold>Provincial distribution</bold></td><td/><td/></tr><tr><td>&#x000a0;Riyadh</td><td align="center">36</td><td align="center">40.45&#x000a0;%</td></tr><tr><td>&#x000a0;Eastern province</td><td align="center">14</td><td align="center">15.73&#x000a0;%</td></tr><tr><td>&#x000a0;Makkah</td><td align="center">11</td><td align="center">12.35&#x000a0;%</td></tr><tr><td>&#x000a0;Asir</td><td align="center">5</td><td align="center">5.61&#x000a0;%</td></tr><tr><td>&#x000a0;Al Madinah</td><td align="center">4</td><td align="center">4.50&#x000a0;%</td></tr><tr><td>&#x000a0;Al Qassim</td><td align="center">4</td><td align="center">4.50&#x000a0;%</td></tr><tr><td>&#x000a0;Hail</td><td align="center">1</td><td align="center">1.12&#x000a0;%</td></tr><tr><td>&#x000a0;Multiple province or cities</td><td align="center">8</td><td align="center">8.98&#x000a0;%</td></tr><tr><td>&#x000a0;Nationwide</td><td align="center">6</td><td align="center">6.74&#x000a0;%</td></tr><tr><td><bold>Details of dimensions</bold></td><td/><td/></tr><tr><td>&#x000a0;OTC dispensation and self-medication</td><td align="center">18</td><td align="center">20.22&#x000a0;%</td></tr><tr><td>&#x000a0;Dispensation of generics, prescription-only medicines, and antibiotics</td><td align="center">18</td><td align="center">20.22&#x000a0;%</td></tr><tr><td>&#x000a0;Dispensing and counseling practices for specific cases</td><td align="center">7</td><td align="center">7.87&#x000a0;%</td></tr><tr><td>&#x000a0;Counseling for various health conditions</td><td align="center">12</td><td align="center">13.48&#x000a0;%</td></tr><tr><td>&#x000a0;Patient safety measures</td><td align="center">18</td><td align="center">20.22&#x000a0;%</td></tr><tr><td>&#x000a0;Clinical services</td><td align="center">11</td><td align="center">12.36&#x000a0;%</td></tr><tr><td>&#x000a0;Satisfaction levels</td><td align="center">5</td><td align="center">5.62&#x000a0;%</td></tr><tr><td>&#x000a0;Community pharmacists' satisfaction</td><td align="center">2</td><td align="center">2.24&#x000a0;%</td></tr><tr><td>&#x000a0;Customers' satisfaction</td><td align="center">3</td><td align="center">3.37&#x000a0;%</td></tr><tr><td><bold>Quality assessment</bold></td><td/><td/></tr><tr><td>&#x000a0;Low (50&#x000a0;%)</td><td align="center">2</td><td align="center">2&#x000a0;%</td></tr><tr><td>&#x000a0;Moderate-low quality (51<italic>&#x02013;</italic>65&#x000a0;%)</td><td align="center">25</td><td align="center">28&#x000a0;%</td></tr><tr><td>&#x000a0;Moderate-high (66<italic>&#x02013;</italic>79&#x000a0;%)</td><td align="center">38</td><td align="center">43&#x000a0;%</td></tr><tr><td>&#x000a0;High (&#x02265; 80&#x000a0;%)</td><td align="center">24</td><td align="center">27&#x000a0;%</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>The reasons for dispensing POMs and antibiotics without prescription by community pharmacists.</p></caption><alt-text id="al0015">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Reasons</th><th align="center">N</th><th align="center">Events</th><th align="center">Total</th><th align="center">Proportion</th><th align="center">95&#x000a0;% CI</th></tr></thead><tbody><tr><td>If not dispensed, the patient can obtain it from any CP</td><td align="center">3</td><td align="center">255</td><td align="center">307</td><td align="center">0.869</td><td align="center">[0.578, 1000]</td></tr><tr><td>Patient&#x02019; socioeconomic status</td><td align="center">3</td><td align="center">330</td><td align="center">583</td><td align="center">0.719</td><td align="center">[0.246, 0.998]</td></tr><tr><td>Simple symptoms</td><td align="center">3</td><td align="center">254</td><td align="center">652</td><td align="center">0.678</td><td align="center">[0.112, 1000]</td></tr><tr><td>Pharmacists' confidence/ knowledge</td><td align="center">5</td><td align="center">378</td><td align="center">832</td><td align="center">0.648</td><td align="center">[0.339, 0.902]</td></tr><tr><td>Difficulties in reaching the clinic</td><td align="center">3</td><td align="center">291</td><td align="center">654</td><td align="center">0.631</td><td align="center">[0.242, 0.941]</td></tr></tbody></table><table-wrap-foot><fn><p>N&#x000a0;=&#x000a0;Total number of included studies.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t0015"><label>Table 3</label><caption><p>The barriers to patient counseling by community pharmacists.</p></caption><alt-text id="al0020">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Barriers</th><th align="center">N</th><th align="center">Events</th><th align="center">Total</th><th align="center">Proportion</th><th align="center">95&#x000a0;% CI</th></tr></thead><tbody><tr><td>Lack of time</td><td align="center">8</td><td align="center">1511</td><td align="center">2990</td><td align="center">0.494</td><td align="center">[0.346, 0.643]</td></tr><tr><td>Lack of reliable sources /information</td><td align="center">4</td><td align="center">638</td><td align="center">2481</td><td align="center">0.222</td><td align="center">[0.102, 0.371]</td></tr><tr><td>Patient culture/not interested</td><td align="center">5</td><td align="center">171</td><td align="center">861</td><td align="center">0.202</td><td align="center">[0.047, 0.424]</td></tr><tr><td>Lack of pharmacists' confidence/ knowledge</td><td align="center">7</td><td align="center">491</td><td align="center">2895</td><td align="center">0.179</td><td align="center">[0.075, 0.313]</td></tr><tr><td>Community pharmacists are not interested</td><td align="center">5</td><td align="center">213</td><td align="center">2267</td><td align="center">0.102</td><td align="center">[0.035, 0.194]</td></tr></tbody></table><table-wrap-foot><fn><p>N&#x000a0;=&#x000a0;Total number of included studies.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t0020"><label>Table 4</label><caption><p>The barriers to ADRs reporting system by community pharmacists.</p></caption><alt-text id="al0025">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Barriers</th><th align="center">N</th><th align="center">Events</th><th align="center">Total</th><th align="center">Proportion</th><th align="center">95&#x000a0;% CI</th></tr></thead><tbody><tr><td>Reporting forms are not available</td><td align="center">4</td><td align="center">219</td><td align="center">374</td><td align="center">0.678</td><td align="center">[0.359, 0.926]</td></tr><tr><td>No motivation</td><td align="center">3</td><td align="center">72</td><td align="center">204</td><td align="center">0.387</td><td align="center">[0.175, 0.624]</td></tr><tr><td>Reporting is time consuming</td><td align="center">4</td><td align="center">109</td><td align="center">374</td><td align="center">0.307</td><td align="center">[0.233, 0.386]</td></tr><tr><td>Fear of legal liability</td><td align="center">3</td><td align="center">59</td><td align="center">204</td><td align="center">0.287</td><td align="center">[0.082, 0.551]</td></tr><tr><td>I am not sure if it's ADRs</td><td align="center">3</td><td align="center">62</td><td align="center">204</td><td align="center">0.280</td><td align="center">[0.000, 0.756]</td></tr><tr><td>Forms are too complicated</td><td align="center">4</td><td align="center">89</td><td align="center">374</td><td align="center">0.236</td><td align="center">[0.194, 0.282]</td></tr><tr><td>Insufficient clinical knowledge</td><td align="center">4</td><td align="center">78</td><td align="center">374</td><td align="center">0.189</td><td align="center">[0.058, 0.370]</td></tr></tbody></table><table-wrap-foot><fn><p>N&#x000a0;=&#x000a0;Total number of included studies.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0030"><label>2.4</label><title>Data collection process</title><p id="p0055">A data collection form, piloted with approximately 10&#x000a0;% of the studies, was created to extract the following items from each study: reference, location, aim, study design, sample size, key findings, and mixed methods appraisal tool (MMAT) score. Individual studies' characteristics are listed separately, based on participant types and outcomes, in chronological order. The data were extracted by KA and cross-checked by MH following the same eligibility criteria process, and differences were resolved by reaching a consensus (<xref rid="ec0015" ref-type="supplementary-material">Supplementary Material 3</xref>).</p></sec><sec id="s0035"><label>2.5</label><title>Quality assessment</title><p id="p0065">The MMAT version 2018 assessed the quality of all included studies.<xref rid="bb0100" ref-type="bibr"><sup>20</sup></xref> The MMAT contains three sets of criteria, one per type of research method (qualitative, quantitative, or mixed methods). Each study was judged on seven methodological criteria; according to the MMAT, a &#x02018;Yes&#x02019; response refers to a criterion's presence, a &#x02018;NO&#x02019; response refers to its absence, and a &#x02018;Cannot tell&#x02019; response indicates that the paper does not report sufficient information to answer or that it reports unclear information. For each criterion, &#x02018;Yes&#x02019; and &#x02018;No&#x02019; responses were scored 1 point and 0 point, respectively, while a &#x02018;Cannot tell&#x02019; response was scored 0.5 points. Each study's score was calculated using the equation [Total points earned &#x000f7; 7 (Total points possible)&#x000a0;&#x000d7;&#x000a0;100&#x000a0;=&#x000a0;Scoring %]. The quality score of each study was classified as low (&#x02264; 50&#x000a0;%), moderate-low (51<italic>&#x02013;</italic>65&#x000a0;%), moderate-high (66<italic>&#x02013;</italic>79&#x000a0;%), or high (&#x02265; 80&#x000a0;%). Two independent reviewers (KA and MH) conducted the quality assessment of all included studies, and the results were then discussed with (LH) to ensure consensus. A standardized Microsoft Excel spreadsheet was created for the quality assessment (<xref rid="ec0020" ref-type="supplementary-material">Supplementary Material 4</xref>).</p><p id="p0075">Studies with low or moderate-low quality (ranging from 50&#x000a0;% to 65&#x000a0;%) were not excluded from the current analyses. This decision ensured that no potentially valuable data would be lost, as even lower-quality studies can provide meaningful information.</p></sec><sec id="s0040"><label>2.6</label><title>Data management, statistical analyses, and synthesis methods</title><p id="p0080">Graphical and numerical descriptive statistics were used to summarize the frequencies and percentages of study characteristics, quality assessment, and key outcomes of CP services. In addition, an analytical statistical assessment was performed using a meta-analysis of proportions utilizing JBI SUMARI software.<xref rid="bb0105" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bb0110" ref-type="bibr"><sup>22</sup></xref> Freeman-Tukey transformation and a random effect model were applied, and the 95&#x000a0;% confidence interval (CI) was estimated. Since different studies utilized different measurement scales to report barriers and reasons for the practice, a cut-off of three or more eligible quantitative studies reporting a similar measurable outcome were included in the analyses. For example, we considered statements such as agreement scores (strongly agree, agree) as &#x0201c;Yes&#x0201d; and disagreement scores (strongly disagree, disagree) as &#x0201c;No&#x0201d;; similarly, &#x02018;always&#x02019;, &#x02018;often&#x02019;, &#x02018;sometimes&#x02019;, and &#x02018;rarely&#x02019; were assigned &#x0201c;Yes&#x0201d;, while &#x02018;never&#x02019; was assigned &#x0201c;No&#x0201d;. Regarding CP services and practice, the eligible quantitative studies reporting a similar measurable outcome in observational studies and simulated patient visits (SPV) were used for meta-analyses. The SPV is a method involving a trained individual who convincingly simulates a standardized scripted request as a realistic patient<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref>; the analysis of these studies considers their direct observations of events and behaviors performed in non-controlled settings to identify gaps in evidence-based practice implementation.<xref rid="bb0120" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="bb0125" ref-type="bibr"><sup>25</sup></xref> A narrative synthesis approach was used to report and discuss the main findings.</p></sec></sec><sec id="s0045"><label>3</label><title>Results</title><p id="p0085">The study selection process initially yielded 3805 studies through the two main phases. In Phase I, 1306 records were identified from the databases, with 71 studies included; in Phase II, 2499 records were identified from citation searching of 71 studies in Phase I, with 18 additional articles. Thus, 89 studies from the two phases were included in the systematic review. <xref rid="f0005" ref-type="fig">Fig. 1</xref>.<fig id="f0005"><label>Fig. 1</label><caption><p>PRISMA flow diagram for systematic review.</p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xlink:href="gr1" id="lk0005"/></fig></p><sec id="s0050"><label>3.1</label><title>Characteristics of included studies</title><p id="p0090">Five key dimensions of CP services and practices were derived from the 89 included studies. These dimensions are medication dispensing, patient counseling, patient safety measures, clinical services and satisfaction level. <xref rid="t0005" ref-type="table">Table 1</xref>.</p></sec><sec id="s0055"><label>3.2</label><title>Medication dispensing</title><sec id="s0060"><label>3.2.1</label><title>Over the counters (OTCs)</title><p id="p0095">A survey study in Riyadh city in 2012 revealed that 70&#x000a0;% of community pharmacists knew the OTC directory,<xref rid="bb0570" ref-type="bibr"><sup>114</sup></xref> but a more recent study in Riyadh in 2020 suggested that only 40&#x000a0;% of them dispensed OTCs according to evidence-based practice.<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref> Herbal medicine dispensation was a common practice of community pharmacists, with poor awareness regarding potential herb-drug interactions.<xref rid="bb0295" ref-type="bibr"><sup>59</sup></xref><sup>,</sup><xref rid="bb0305" ref-type="bibr"><sup>61</sup></xref><sup>,</sup><xref rid="bb0315" ref-type="bibr"><sup>63</sup></xref><sup>,</sup><xref rid="bb0320" ref-type="bibr"><sup>64</sup></xref> Two studies explored dispensing vitamin and nutritional supplements and found this to be a common practice, with adequate scientific knowledge.<xref rid="bb0325" ref-type="bibr"><sup>65</sup></xref><sup>,</sup><xref rid="bb0345" ref-type="bibr"><sup>69</sup></xref> There is a lack of basic knowledge of weight-reduction (diet) products among pharmacists, who believe these products are effective and safe, as one study reported.<xref rid="bb0310" ref-type="bibr"><sup>62</sup></xref> Proton pump inhibitors (anti-ulcer medicines or stomach acidity reducers) were addressed in only one study, and most pharmacists claimed that they knew about their indications and side effects, with 94&#x000a0;% of them dispensing proton pump inhibitors to their patients.<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref> Oral healthcare was examined by two studies, which found a lack of oral health knowledge among pharmacists.<xref rid="bb0360" ref-type="bibr"><sup>72</sup></xref><sup>,</sup><xref rid="bb0575" ref-type="bibr"><sup>115</sup></xref> One study evaluated the awareness level of sunscreens and moisturizer products, revealing that most pharmacists need more understanding of cosmetics.<xref rid="bb0340" ref-type="bibr"><sup>68</sup></xref></p></sec><sec id="s0065"><label>3.2.2</label><title>Self-medication</title><p id="p0100">Self-medication patterns were discussed in six studies. One study, exploring the topic from pharmacists' perspectives, showed that self-medication is more common among men than women,<xref rid="bb0580" ref-type="bibr"><sup>116</sup></xref> with similar findings across four studies examining the public perspective.<xref rid="bb0225" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="bb0500" ref-type="bibr">100</xref>, <xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref> People with low education levels and non-healthcare professionals were more likely to prefer self-medication.<xref rid="bb0225" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="bb0505" ref-type="bibr"><sup>101</sup></xref> The overall proportion of self-medication for minor symptoms by the public was 0.712 with 95&#x000a0;% CI [0.495, <italic>0.886</italic>] presented in <xref rid="t0025" ref-type="table">Table 5</xref>. More details in <xref rid="f0005" ref-type="fig">Fig. 1</xref>, <xref rid="ec0025" ref-type="supplementary-material">Supplementary Material 5</xref>.</p></sec><sec id="s0070"><label>3.2.3</label><title>Generic medicines</title><p id="p0110">Most pharmacists prefer to dispense generic medicines (i.e., drugs with the same active-ingredient formula as brand-name drugs), but they need to know more about the efficacy and safety profiles of such medicines. According to retrieved studies, cutting costs for the customer based on physical appearance and product bonuses offered by pharmaceutical companies were the main factors behind community pharmacists dispensing generic medicines.<xref rid="bb0185" ref-type="bibr">37</xref>, <xref rid="bb0190" ref-type="bibr">38</xref>, <xref rid="bb0195" ref-type="bibr">39</xref><table-wrap position="float" id="t0025"><label>Table 5</label><caption><p>The overall meta-analyses of proportion of Saudi CP practice 2010&#x02013;2020.</p></caption><alt-text id="al0030">Table 5</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Practice</th><th align="center">N</th><th align="center">Events</th><th align="center">Total</th><th align="center">Proportion</th><th align="center">95&#x000a0;% CI</th></tr></thead><tbody><tr><td>Public practiced self-medication for minor symptoms</td><td align="center">5</td><td align="center">2678</td><td align="center">3723</td><td align="center">0.712</td><td align="center">[0.495&#x02013;0.886]</td></tr><tr><td>Pharmacists dispensed POMs without prescription</td><td align="center">4</td><td align="center">491</td><td align="center">863</td><td align="center">0.717</td><td align="center">[0.497&#x02013;0.894]</td></tr><tr><td>Pharmacists dispensed antibiotics without prescription<break/>(before it was outlawed)</td><td align="center">4</td><td align="center">447</td><td align="center">541</td><td align="center">0.931</td><td align="center">[0.795&#x02013;0.999]</td></tr><tr><td>Pharmacists dispensed antibiotics without prescription<break/>(after it was outlawed)</td><td align="center">3</td><td align="center">142</td><td align="center">548</td><td align="center">0.336</td><td align="center">[0.001&#x02013;0.857]</td></tr><tr><td>Pharmacists asked about associated symptoms</td><td align="center">4</td><td align="center">787</td><td align="center">1468</td><td align="center">0.557</td><td align="center">[0.408&#x02013;0.701]</td></tr><tr><td>Pharmacists asked about concomitant drugs/comorbidities</td><td align="center">4</td><td align="center">307</td><td align="center">1264</td><td align="center">0.151</td><td align="center">[0.037&#x02013;0.320]</td></tr><tr><td>Pharmacists asked if the patient had taken this medicine before</td><td align="center">4</td><td align="center">72</td><td align="center">769</td><td align="center">0.096</td><td align="center">[0.049&#x02013;0.156]</td></tr><tr><td>Pharmacists asked about drug allergy</td><td align="center">6</td><td align="center">72</td><td align="center">1696</td><td align="center">0.046</td><td align="center">[0.013&#x02013;0.097]</td></tr><tr><td>Pharmacists asked about pregnancy status</td><td align="center">3</td><td align="center">29</td><td align="center">279</td><td align="center">0.251</td><td align="center">[0.001&#x02013;0.664]</td></tr><tr><td>Pharmacists provided duration of use</td><td align="center">4</td><td align="center">300</td><td align="center">1090</td><td align="center">0.276</td><td align="center">[0.026&#x02013;0.654]</td></tr><tr><td>Pharmacists demonstrated the correct use of metered dose inhaler steps</td><td align="center">3</td><td align="center">18</td><td align="center">335</td><td align="center">0.049</td><td align="center">[0.021&#x02013;0.086]</td></tr><tr><td>Pharmacists' familiarity with the ADRs reporting system</td><td align="center">6</td><td align="center">231</td><td align="center">577</td><td align="center">0.384</td><td align="center">[0.135&#x02013;0.670]</td></tr></tbody></table><table-wrap-foot><fn><p>N&#x000a0;=&#x000a0;Total number of included studies.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0075"><label>3.2.4</label><title>Prescription only medicines (POMs)</title><p id="p0115">Malpractice in drug dispensation was observed in 15 studies. POMs, including antibiotics, are medicines which cannot otherwise be dispensed without an authorized prescription.<xref rid="bb0200" ref-type="bibr">40</xref>, <xref rid="bb0205" ref-type="bibr">41</xref>, <xref rid="bb0210" ref-type="bibr">42</xref><sup>,</sup><xref rid="bb0220" ref-type="bibr">44</xref>, <xref rid="bb0225" ref-type="bibr">45</xref>, <xref rid="bb0230" ref-type="bibr">46</xref><sup>,</sup><xref rid="bb0240" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="bb0245" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bb0255" ref-type="bibr"><sup>51</sup></xref><sup>,</sup><xref rid="bb0270" ref-type="bibr"><sup>54</sup></xref><sup>,</sup><xref rid="bb0470" ref-type="bibr"><sup>94</sup></xref><sup>,</sup><xref rid="bb0475" ref-type="bibr"><sup>95</sup></xref><sup>,</sup><xref rid="bb0585" ref-type="bibr">117</xref>, <xref rid="bb0590" ref-type="bibr">118</xref>, <xref rid="bb0595" ref-type="bibr">119</xref> Three studies evaluated the impact of law enforcement found that antibiotics continue to be dispensed without a prescription by community pharmacists.<xref rid="bb0280" ref-type="bibr">56</xref>, <xref rid="bb0285" ref-type="bibr">57</xref>, <xref rid="bb0290" ref-type="bibr">58</xref> The overall proportion of dispensing POMs was 0.717 with 95&#x000a0;% CI [0.497, 0.894]; the proportion of dispensing antibiotics without a prescription before it was outlawed was 0.931 with 95&#x000a0;% CI [0.795, 0.999], and after it was outlawed, the proportion was 0.336 with 95&#x000a0;% CI [0.001, 0.857]. More details are in Figs. 2 and 3, <xref rid="ec0025" ref-type="supplementary-material">Supplementary Material 5</xref>. Five studies listed the reasons reported most frequently by community pharmacists for dispensing POMs, including antibiotics.<xref rid="bb0205" ref-type="bibr"><sup>41</sup></xref><sup>,</sup><xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref><sup>,</sup><xref rid="bb0230" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bb0255" ref-type="bibr"><sup>51</sup></xref><sup>,</sup><xref rid="bb0590" ref-type="bibr"><sup>118</sup></xref>
<xref rid="t0010" ref-type="table">Table 2</xref>.</p></sec></sec><sec id="s0080"><label>3.3</label><title>Patient counseling</title><p id="p0125">Several retrieved studies evaluated the quality of community pharmacists' patient counseling for multiple health conditions.<xref rid="bb0130" ref-type="bibr">26</xref>, <xref rid="bb0135" ref-type="bibr">27</xref>, <xref rid="bb0140" ref-type="bibr">28</xref>, <xref rid="bb0145" ref-type="bibr">29</xref>, <xref rid="bb0150" ref-type="bibr">30</xref>, <xref rid="bb0155" ref-type="bibr">31</xref><sup>,</sup><xref rid="bb0235" ref-type="bibr"><sup>47</sup></xref><sup>,</sup><xref rid="bb0460" ref-type="bibr"><sup>92</sup></xref> Their findings revealed poor recognition among community pharmacists of the use of Metered Dose Inhalers,<xref rid="bb0170" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="bb0465" ref-type="bibr"><sup>93</sup></xref><sup>,</sup><xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref> while one study showed community pharmacists were competent enough in counseling asthma patients.<xref rid="bb0170" ref-type="bibr"><sup>34</sup></xref> Interestingly, out of the 89 included studies, only one interventional study found that clinical programs by community pharmacists to counsel people with diabetes were effective in raising patients' awareness.<xref rid="bb0565" ref-type="bibr"><sup>113</sup></xref></p><p id="p0130">One study concluded that the most relevant counseling attributes from the public's perspective were the quality of the information provided during counseling, the pharmacist's experience and education, and the explanation of associated side effects and drug-drug interactions.<xref rid="bb0480" ref-type="bibr"><sup>96</sup></xref> According to the meta-analyses, the highest proportion of questions by community pharmacists during patient counseling was for associated symptoms (0.557), and the lowest was for asking about drug allergies (0.046). More details are in Figs. 4 and 5, <xref rid="ec0025" ref-type="supplementary-material">Supplementary Material 5</xref>. Eight studies reported the top five barriers to patient counseling for various health conditions among community pharmacists.<xref rid="bb0130" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="bb0135" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bb0180" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="bb0320" ref-type="bibr"><sup>64</sup></xref><sup>,</sup><xref rid="bb0360" ref-type="bibr"><sup>72</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0605" ref-type="bibr"><sup>121</sup></xref><sup>,</sup><xref rid="bb0610" ref-type="bibr"><sup>122</sup></xref> The barriers to patient counseling are presented in <xref rid="t0015" ref-type="table">Table 3</xref>.</p></sec><sec id="s0085"><label>3.4</label><title>Patient safety measures</title><p id="p0140">Two studies investigated the proportions of errors in dispensing medications by community pharmacists. The top five factors contributing to dispensing errors were look-alike and sound-alike medicines (e.g., visually similar packaging or similar phonetics), fatigue, generic medicines, lack of privacy when dispensing, and interruptions.<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref> Prescribing errors in physicians' prescriptions were reported to be common. The quality of written prescriptions was deficient in some elements (e.g., patient name and age, date, and diagnosis).<xref rid="bb0375" ref-type="bibr"><sup>75</sup></xref></p><p id="p0145">One study shed light on the ethical issues for community pharmacists, including dispensing doses outside the national formulary and controlled drugs, resulting in a need for more knowledge on these ethical issues.<xref rid="bb0610" ref-type="bibr"><sup>122</sup></xref> According to another study, 36&#x000a0;% of community pharmacists believe administering controlled medications without a prescription is necessary for their income, and 14&#x000a0;% reported a complete absence of monitoring of their services by authorities.<xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref> The antimicrobial stewardship program in CP was found to be substandard, indicating a need for significant improvement in this area.<xref rid="bb0275" ref-type="bibr"><sup>55</sup></xref> Two other studies focused on CPs' preventive measures during the COVID-19 pandemic. One study, which used self-administered surveys, demonstrated readiness among pharmacists<xref rid="bb0410" ref-type="bibr"><sup>82</sup></xref>; by contrast, the other study, which used a SPV, shown poor compliance with preventive measures against COVID-19, underscoring the need for better adherence to safety protocols.<xref rid="bb0415" ref-type="bibr"><sup>83</sup></xref></p><p id="p0150">One study evaluated medication safety during pregnancy; in this respect, community pharmacists did not always offer correct advice to pregnant women or ask female patients about their pregnancy status.<xref rid="bb0370" ref-type="bibr"><sup>74</sup></xref> Another study evaluated common potential drug-drug interactions among 26 drug pairs and found that community pharmacists' knowledge on this topic needed to be improved.<xref rid="bb0380" ref-type="bibr"><sup>76</sup></xref></p><p id="p0155">Two studies explored medication safety problems; factors contributing to medication safety problems included commercial pressures on community pharmacists by pharmaceutical companies, a lack of enforcement of regulations, the fragmented healthcare system (control, regulation, and lack of patient database), and self-medication.<xref rid="bb0555" ref-type="bibr"><sup>111</sup></xref> In addition, the priorities of medication safety problems were lack of pharmacy counseling area, lack of communication with physicians, lack of patient databases, lack of post-registration pharmacist education, and long working hours.<xref rid="bb0550" ref-type="bibr"><sup>110</sup></xref></p><p id="p0160">Only half of community pharmacists screened for the associated risk factors of nonsteroidal anti-inflammatory drugs for their patients and provided advice regarding adverse drug reactions (ADRs).<xref rid="bb0160" ref-type="bibr"><sup>32</sup></xref> Seven studies on the community pharmacists' perspective revealed a poor understanding of the ADR reporting system.<xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0430" ref-type="bibr">86</xref>, <xref rid="bb0435" ref-type="bibr">87</xref>, <xref rid="bb0440" ref-type="bibr">88</xref>, <xref rid="bb0445" ref-type="bibr">89</xref>, <xref rid="bb0450" ref-type="bibr">90</xref> A nationwide study involving 5228 participants on the public's perspective estimated the prevalence and awareness of ADR reporting<xref rid="bb0485" ref-type="bibr"><sup>97</sup></xref>: of the participants, 28&#x000a0;% experienced an ADR over the course of a year; of those who experienced an ADR, only 30.26&#x000a0;% were aware of the reporting system, and only 14.29&#x000a0;% filed a report. According to this review, the overall proportion with respect to community pharmacists' familiarity with the reporting system was 0.384 with 95&#x000a0;% CI [0.135, 0.670]. More details are in Figs. 6 and 7, <xref rid="ec0025" ref-type="supplementary-material">Supplementary Material 5</xref>. Four studies reported the barriers to ADR reporting which were shared by community pharmacists.<xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref><sup>,</sup><xref rid="bb0435" ref-type="bibr"><sup>87</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref>
<xref rid="t0020" ref-type="table">Table 4</xref>.</p></sec><sec id="s0090"><label>3.5</label><title>Clinical services</title><p id="p0170">As determined from the retrieved studies, many critical clinical services were lacking and did not meet international standards, with no computerized documentation system in place.<xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref> Additionally, the current practice of Saudi CPs is product-oriented, rather than focused on actual pharmaceutical care.<xref rid="bb0060" ref-type="bibr"><sup>12</sup></xref> Approximately 53&#x000a0;% of community pharmacists thought they were knowledgeable about the concept of pharmaceutical care.<xref rid="bb0395" ref-type="bibr"><sup>79</sup></xref> As a result, effective clinical services are bound by community pharmacists' knowledge, needs, values, and trust; therefore, 66&#x000a0;% of them denied practicing clinical services.<xref rid="bb0400" ref-type="bibr"><sup>80</sup></xref> In terms of the public's perspective, chronic disease patients reported not having experienced such clinical services and a lack of trust in community pharmacists<xref rid="bb0520" ref-type="bibr"><sup>104</sup></xref><sup>,</sup><xref rid="bb0615" ref-type="bibr"><sup>123</sup></xref>; additionally, 96&#x000a0;% of the Saudi public perceived medication-therapy management service as beneficial for patients' care.<xref rid="bb0545" ref-type="bibr"><sup>109</sup></xref> One study evaluated the association between diabetic patients' knowledge and their medication adherence and found that half of those with disease knowledge were more likely to have high adherence.<xref rid="bb0490" ref-type="bibr"><sup>98</sup></xref></p><p id="p0175">Two studies reported on the provision of immunization services in CPs. One found that 45&#x000a0;% of community pharmacists were unwilling to provide immunization services for various reasons, including lack of training, concerns about patient safety, and the resultant increased workload.<xref rid="bb0405" ref-type="bibr"><sup>81</sup></xref> For their part, the public expressed a need for immunization services, but there were concerns about pharmacists' training, the lack of a private area to conduct the service, the gender of the pharmacist, and the cost of the service.<xref rid="bb0525" ref-type="bibr"><sup>105</sup></xref> Finally, only one study highlighted the importance of interprofessional collaboration between physicians and community pharmacists regarding clinical services: while community pharmacists would like to have better relationships with physicians, physicians need to be made aware of the role of community pharmacists.<xref rid="bb0560" ref-type="bibr"><sup>112</sup></xref></p></sec><sec id="s0095"><label>3.6</label><title>Satisfaction level</title><p id="p0180">Two studies measured job satisfaction among community pharmacists. Pharmacists who worked in independent CPs had lower satisfaction levels<xref rid="bb0420" ref-type="bibr"><sup>84</sup></xref>; long working hours, workload, duty shifts, difficulty obtaining personal or sick leave, and low salaries were job stressors related to patient care responsibility.<xref rid="bb0420" ref-type="bibr"><sup>84</sup></xref><sup>,</sup><xref rid="bb0425" ref-type="bibr"><sup>85</sup></xref> The professional performance of community pharmacists was below expectations according to three studies involving the public: 37&#x000a0;% perceived community pharmacists as mere vendors, and 48&#x000a0;% did not receive enough counseling.<xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref><sup>,</sup><xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref> Only 41&#x000a0;% of the public reported being satisfied with overall services,<xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref> and only 35.3&#x000a0;% of Saudi women were satisfied with male community pharmacists' services, while 63&#x000a0;% found it embarrassing to discuss issues with male community pharmacists.<xref rid="bb0540" ref-type="bibr"><sup>108</sup></xref>
<xref rid="t0025" ref-type="table">Table 5</xref> illustrates the overall meta-analyses of the proportion of Saudi CP practice 2010&#x02013;2020.</p></sec></sec><sec id="s0100"><label>4</label><title>Discussion</title><p id="p0185">This systematic review is timely and crucial for the Saudi transformation program based on Saudi Vision 2030, which expands the role of CPs to include patient-centered healthcare provision: the national transformation plan contains a proposal to transfer all outpatient pharmacy services from the public sector to CPs.<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref> The review's key findings revealed the prevalence of the practice of self-medication, malpractice in dispensing POMs, a deficiency in patient counseling, and many factors contributing to patient safety problems and low satisfaction levels due to the lack of patient-centered care.</p><p id="p0190">The results of 89 research studies reveal an urgent need for more trial studies and interventional studies, as well as a lack of the perspectives of physicians, female community pharmacists, and CP owners and managers. However, a noticeable trend was observed in conjunction with the launch of Saudi Vision 2030 in 2016, whereafter both methodological quality and publishing quantity of studies increased notably, involving more public and other stakeholders. Regardless, most community pharmacists were male. The possible reason for the absence of women's participation is that pharmacy colleges for women in SA were only opened recently, leading to a persistent gender imbalance in the CP workforce. In addition, female pharmacists prefer working in the government sector, for personal and household stability reasons.<xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref> Most Saudi women were unsatisfied with CP services and found it embarrassing to discuss issues with male community pharmacists, necessitating the empowerment of female pharmacists in CP in SA.<xref rid="bb0065" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bb0540" ref-type="bibr"><sup>108</sup></xref></p><p id="p0195">Self-medication is a widespread global phenomenon in which individuals take non-prescription medication without the advice of a healthcare professional or prescription, which may lead to health problems such as ADRs or drug-drug interactions.<xref rid="bb0620" ref-type="bibr"><sup>124</sup></xref> The review's findings show that people in SA often practice self-medication for minor health issues; however, the retrieved studies suggest that stakeholders should address the factors which lead to self-medication&#x02014;including avoiding long waits at clinics and hospitals, seeking quicker relief, and the potential cost savings&#x02014;revealed in several studies.<xref rid="bb0350" ref-type="bibr"><sup>70</sup></xref><sup>,</sup><xref rid="bb0500" ref-type="bibr">100</xref>, <xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref> Additionally, the need for local health authorities to raise public awareness about the danger of self-medication may enhance patient health literacy and limit this phenomenon. The OTC directory and pharmacist prescriptions should be re-evaluated, due to conflicts with available guidelines.<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref> Implementing evidence-based practice guidelines for OTC medications can support community pharmacists' practice and improve health outcomes.<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref></p><p id="p0200">In 2018, the Saudi MOH released an official law to reduce the widespread practice of dispensing POMs, including antibiotics. This malpractice is credited with the rise of certain global public health problems, such as microbial resistance, placing a financial burden on healthcare systems and patients. In addition, OTC dispensing of antibiotics can lead to inappropriate use, such as for viral infections (e.g., colds and flu), where they are ineffective, potentially contributing to side effects.<xref rid="bb0620" ref-type="bibr"><sup>124</sup></xref> According to the review's findings, community pharmacists claimed that patients would easily obtain antibiotics from other CP sources despite being prohibited by some CPs. Another main reason was a patient's economic status&#x02014;i.e., some patients cannot afford to visit a physician. However, these reasons were reported in several studies before the law came into force. Nevertheless, some community pharmacists still violate the law, with one-third of antibiotics dispensed without a prescription. Conceptually, community pharmacists' practices with respect to antimicrobial stewardship application in SA are poor.<xref rid="bb0275" ref-type="bibr"><sup>55</sup></xref> Addressing possible cultural and social barriers requires a multifaceted approach, including public awareness campaigns, education on the appropriate use of antibiotics, and consolidated monitoring of antibiotic sales, which would likely limit this phenomenon.<xref rid="bb0240" ref-type="bibr"><sup>48</sup></xref><sup>,</sup><xref rid="bb0280" ref-type="bibr"><sup>56</sup></xref></p><p id="p0205">Patient counseling, the backbone of pharmaceutical care, involves providing information, advice, and support to assist patients with their medication use. Evidence indicates that counseling by community pharmacists improves clinical outcomes.<xref rid="bb0135" ref-type="bibr"><sup>27</sup></xref> However, this review predominantly revealed a deficiency in patient counseling. At the local level, most of the public receives suboptimal counseling at the cashier counter and in the presence of other nearby customers.<xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref><sup>,</sup><xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref><sup>,</sup><xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref><sup>,</sup><xref rid="bb0545" ref-type="bibr"><sup>109</sup></xref><sup>,</sup><xref rid="bb0625" ref-type="bibr"><sup>125</sup></xref> Counseling deficiencies among community pharmacists could seriously impact their ability to provide adequate overall pharmaceutical care, and insufficient continuing professional development, reliable sources, and support from CP management in the face of high workload and stress lead to low health outcomes.<xref rid="bb0630" ref-type="bibr">126</xref>, <xref rid="bb0635" ref-type="bibr">127</xref>, <xref rid="bb0640" ref-type="bibr">128</xref> Ensuring that community pharmacists are well-equipped with counseling skills and therapeutic knowledge requires the classification and registration of community pharmacists by the Saudi Commission for Health Specialties to be reviewed and re-evaluated. More importantly, policies and guidelines for counseling practice need to be implemented, so as to standardize the level of services provided by CP.<xref rid="bb0155" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bb0630" ref-type="bibr"><sup>126</sup></xref> Additionally, the barriers to patient counseling reported in this review&#x02014;the main factors being lack of time and reliable sources&#x02014;must be addressed by CP owners and managers.</p><p id="p0210">Medication errors can occur at any stage of the medication delivery process, and they compromise patient safety. According to a recent international systematic review, contributing factors to such errors include inadequate training, knowledge gaps, and high workloads for healthcare practitioners.<xref rid="bb0645" ref-type="bibr"><sup>129</sup></xref> Similar to global findings, the common factors leading to medication errors in Saudi CPs were look-alike/sound-alike medicines, generic medicines, lack of privacy when dispensing, and interruption while counseling.<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0550" ref-type="bibr"><sup>110</sup></xref> Additionally, prescribing errors are common in physicians' prescriptions and are associated with low-quality, handwritten prescriptions which lack essential information such as the patient's name, age, date, and diagnosis.<xref rid="bb0375" ref-type="bibr"><sup>75</sup></xref> To this end, computerized medication prescriptions&#x02014;such as the national electronic prescription &#x02018;Wasfaty&#x02019;, supported with software to detect drug-drug interaction&#x02014;would be vital to reducing medication errors.<xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref> The monitoring of medication safety standards by local authorities would ensure that community pharmacists are continually trained to prescribe and dispense appropriate medicines safely.</p><p id="p0215">Medication errors exist in relationship to ADRs.<xref rid="bb0650" ref-type="bibr"><sup>130</sup></xref> The meta-analysis results indicate that most community pharmacists needed a better understanding of the ADR reporting system process. This poor understanding also extends to the public, who needed to be made aware of the reporting system.<xref rid="bb0485" ref-type="bibr"><sup>97</sup></xref> However, most community pharmacists claimed that the reporting form was unavailable, the forms were too complicated, or they were afraid of legal liability.<xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref><sup>,</sup><xref rid="bb0435" ref-type="bibr"><sup>87</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref> Although the National Pharmacovigilance and Drug Safety Centre offers online guidance on ADRs and events, educational programs and awareness campaigns should continue to advocate for ADR reporting by community pharmacists and the public.<xref rid="bb0655" ref-type="bibr"><sup>131</sup></xref></p><p id="p0220">Steps have been taken in many industrialized countries to equip community pharmacists with key responsibilities and provide integrated healthcare services, aligning with the United Nations Sustainable Goals 2030. For example, community pharmacists in Australia, the United Kingdom, and the United States manage chronic diseases. Additionally, pharmacists can provide public health programs such as smoking cessation and bodyweight management as part of their essential practice. Public health screenings (e.g., vital signs, blood glucose and blood pressure measurements) can also be provided by CPs.<xref rid="bb0660" ref-type="bibr"><sup>132</sup></xref> One key issue which needs to be addressed in the National Transformation Program is the need for more patient-centered care in Saudi CPs. Many of these essential clinical services need to be improved or introduced.<xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref> However, only half of community pharmacists knew about clinical services, leading to missed opportunities to practice these services.<xref rid="bb0400" ref-type="bibr"><sup>80</sup></xref> However, the Saudi MOH recently introduced a package of CP services.<xref rid="bb0665" ref-type="bibr"><sup>133</sup></xref> A pharmacist with a certificate in pharmacy-based immunization delivery can deliver several vaccinations. In addition, some public health screening services are possible, including measuring blood pressure, heart rate, body temperature, and body mass index.<xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref> Clinical pharmacists can also treat some minor illnesses and offer medication therapy management.<xref rid="bb0675" ref-type="bibr"><sup>135</sup></xref></p><p id="p0225">However, factors such as long working hours, managerial duties, limited personal leave, and low salaries may hinder community pharmacists from providing clinical services, as this review indicated.<xref rid="bb0425" ref-type="bibr"><sup>85</sup></xref><sup>,</sup><xref rid="bb0680" ref-type="bibr"><sup>136</sup></xref> According to recent local studies, more factors may affect CP performance and quality of service; concluded that 20 factors, falling into four main dimensions (personal, contextual, operational, and healthcare system), might affect CPs' ability to deliver such services, with their top factors being inadequate pharmaceutical care training, lack of collaboration with physicians, lack of a pharmacy clinic, and lack of access to patients' medical records.<xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref> In any case, members of the public with chronic diseases reported not having experienced clinical services<xref rid="bb0520" ref-type="bibr"><sup>104</sup></xref><sup>,</sup><xref rid="bb0615" ref-type="bibr"><sup>123</sup></xref>; consequently, the professional performance of community pharmacists was below expectations in the public's view.<xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref><sup>,</sup><xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref></p><p id="p0230">Some possible strategies to overcome these barriers to offering specialized services are enhancing community pharmacists' clinical knowledge and skills through specific training in clinical skills, patient education programs on the rational use of medicines, improvements in interdisciplinary collaboration with physicians via a clear policy, and effective cooperation between health authorities to successfully transform practice.<xref rid="bb0060" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0400" ref-type="bibr"><sup>80</sup></xref><sup>,</sup><xref rid="bb0560" ref-type="bibr"><sup>112</sup></xref> At this point, a multi-stakeholder approach for developing a national system of measurable quality indicators for CP care is urgently needed.<xref rid="bb0690" ref-type="bibr"><sup>138</sup></xref> Recently, the International Pharmaceutical Federation has developed the Global Competency Framework for effective and sustained performance and advanced practice.<xref rid="bb0695" ref-type="bibr"><sup>139</sup></xref> Therefore, implementing standards for accreditation could create a competitive environment for CP, granting them service remuneration and enhancing customers' confidence in the quality and safety of pharmaceutical care.<xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref></p></sec><sec id="s0105"><label>5</label><title>Strengths and limitations</title><p id="p0235">This is the first systematic review and meta-analyses to involve a multi<bold>-</bold>stakeholder perspective of quantitative and qualitative approaches towards CP services in SA. Using the mixed methods approach provides a better understanding of research problems and complex phenomena.<xref rid="bb0700" ref-type="bibr"><sup>140</sup></xref> It puts findings into context, and allows to explore different dimensions in the transition of CP services towards a more patient-centered model. Nevertheless, the period of this review should be considered as a baseline for performance assessment that can be used to assess change over time. This review summarized the level of Saudi CP services and the extent of satisfaction with services, and it investigated barriers to adequate practice, from 2010 to 2020; the goal of this was to empower decision-makers, CP owners, CP managers, and community pharmacists to take the necessary steps to improve service performance.</p><p id="p0240">In this review, we have included several studies of low and moderate-low quality. However, including all eligible studies, regardless of quality, can provide a more comprehensive overview of the existing evidence on topic,<xref rid="bb0705" ref-type="bibr"><sup>141</sup></xref> as including all studies and then transparently assessing their quality can provide a balanced view.<xref rid="bb0710" ref-type="bibr"><sup>142</sup></xref> High heterogeneity is expected in meta-analyses, due to differences in studies' populations, methodologies, settings, and time periods.<xref rid="bb0705" ref-type="bibr"><sup>141</sup></xref> A random-effects model was used to account for this heterogeneity, since no subgroup analysis was possible, and meta-regression was not considered due to small studies size.<xref rid="bb0715" ref-type="bibr"><sup>143</sup></xref> Publication bias, funnel plots, sensitivity, and specificity tests are neither common nor recommended for proportional meta-analyses and might not be suitable or informative for proportional data<xref rid="bb0720" ref-type="bibr"><sup>144</sup></xref>; therefore, we did not conduct any of these tests.</p></sec><sec id="s0110"><label>6</label><title>Conclusion</title><p id="p0245">The services provided by Saudi CPs in 2010&#x02013;2020 were below expectations. Self-medication for minor ailments was common among the public, and CPs dispensed antibiotic drugs without a prescription. Medication safety problems associated with patient counseling and medication delivery issues were observed. A lack of knowledge about clinical skills leads to a lack of practice in clinical services. Low job satisfaction among community pharmacists could hinder services. Given the inadequate performance of CP services&#x02014;which fall outside the national transformation plan for CP partnerships providing outpatient pharmacy services&#x02014;the findings of this review sound the alarm about the urgency of intensifying efforts to align with Saudi Vision 2030. More studies are needed for further assessment.</p><p id="p0250">The following are the supplementary data related to this article.<supplementary-material content-type="local-data" id="ec0005"><caption><title>Supplementary material 1</title><p>PRISMA 2020 checklist.</p></caption><media xlink:href="mmc1.pdf"><alt-text>Supplementary material 1</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="ec0010"><caption><title>Supplementary material 2</title><p>Systematic search strategy.</p></caption><media xlink:href="mmc2.pdf"><alt-text>Supplementary material 2</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="ec0015"><caption><title>Supplementary material 3</title><p>Summary of studies' characteristics and key findings.</p></caption><media xlink:href="mmc3.pdf"><alt-text>Supplementary material 3</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="ec0020"><caption><title>Supplementary material 4</title><p>Quality assessment.</p></caption><media xlink:href="mmc4.pdf"><alt-text>Supplementary material 4</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="ec0025"><caption><title>Supplementary material 5</title><p>Forest plots of meta-analysis.</p></caption><media xlink:href="mmc5.pdf"><alt-text>Supplementary material 5</alt-text></media></supplementary-material></p></sec><sec id="s0120"><title>CRediT authorship contribution statement</title><p id="p0265"><bold>Khalid S. Alghamdi:</bold> Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. <bold>Max Petzold:</bold> Writing &#x02013; review &#x00026; editing, Supervision, Methodology, Conceptualization. <bold>Mahdi H. Alsugoor:</bold> Writing &#x02013; review &#x00026; editing, Validation, Methodology, Formal analysis, Data curation. <bold>Hafiz A. Makeen:</bold> Writing &#x02013; review &#x00026; editing, Validation, Methodology. <bold>Christina Ljungberg Persson:</bold> Writing &#x02013; original draft, Supervision, Methodology, Formal analysis. <bold>Laith Hussain-Alkhateeb:</bold> Writing &#x02013; review &#x00026; editing, Validation, Supervision, Methodology, Investigation, Formal analysis, Data curation, Conceptualization.</p></sec><sec id="s0115"><title>Funding</title><p id="p0260">This systematic review is a part of PhD project sponsored by <funding-source id="gts0005">Al Baha University</funding-source>, Saudi Arabia.</p></sec><sec sec-type="COI-statement" id="coi0005"><title>Declaration of competing interest</title><p id="p0270">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Mossialos</surname><given-names>E.</given-names></name><name><surname>Courtin</surname><given-names>E.</given-names></name><name><surname>Naci</surname><given-names>H.</given-names></name><etal/></person-group><article-title>From &#x0201c;retailers&#x0201d; to health care providers: transforming the role of community pharmacists in chronic disease management</article-title><source>Health Policy</source><volume>119</volume><issue>5</issue><year>2015</year><fpage>628</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">25747809</pub-id>
</element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Goode</surname><given-names>J.-V.</given-names></name><name><surname>Owen</surname><given-names>J.</given-names></name><name><surname>Page</surname><given-names>A.</given-names></name><name><surname>Gatewood</surname><given-names>S.</given-names></name></person-group><article-title>Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States</article-title><source>Pharmacy</source><volume>7</volume><issue>3</issue><year>2019</year><fpage>106</fpage><pub-id pub-id-type="pmid">31382690</pub-id>
</element-citation></ref><ref id="bb0015"><label>3.</label><element-citation publication-type="other" id="rf0015"><person-group person-group-type="author"><name><surname>PSNC</surname></name></person-group><article-title>Advanced Services</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://psnc.org.uk/national-pharmacy-services/advanced-services/" id="ir0010">https://psnc.org.uk/national-pharmacy-services/advanced-services/</ext-link><year>2013</year></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S.C.A.</given-names></name><name><surname>Glass</surname><given-names>B.</given-names></name></person-group><article-title>Systematic review of expanded practice in rural community pharmacy</article-title><source>J Pharm Pract Res</source><volume>49</volume><issue>6</issue><year>2019</year><fpage>585</fpage><lpage>600</lpage></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name><surname>Sakeena</surname><given-names>M.H.F.</given-names></name><name><surname>Bennett</surname><given-names>A.A.</given-names></name><name><surname>McLachlan</surname><given-names>A.J.</given-names></name></person-group><article-title>Enhancing pharmacists&#x02019; role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review</article-title><source>Antimicrob Resist Infect Control</source><volume>7</volume><year>2018</year><fpage>63</fpage><pub-id pub-id-type="pmid">29744044</pub-id>
</element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name><surname>Ilardo</surname><given-names>M.L.</given-names></name><name><surname>Speciale</surname><given-names>A.</given-names></name></person-group><article-title>The community pharmacist: perceived barriers and patient-centered care communication</article-title><source>Int J Environ Res Public Health</source><volume>17</volume><issue>2</issue><year>2020</year></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Malet-Larrea</surname><given-names>A.</given-names></name><name><surname>Garcia-Cardenas</surname><given-names>V.</given-names></name><name><surname>Saez-Benito</surname><given-names>L.</given-names></name><name><surname>Benrimoj</surname><given-names>S.I.</given-names></name><name><surname>Calvo</surname><given-names>B.</given-names></name><name><surname>Goyenechea</surname><given-names>E.</given-names></name></person-group><article-title>Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review</article-title><source>Expert Rev Pharmacoecon Outcomes Res</source><volume>16</volume><issue>6</issue><year>2016</year><fpage>747</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">27828725</pub-id>
</element-citation></ref><ref id="bb0040"><label>8.</label><element-citation publication-type="other" id="rf0040"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Statistical Yearbook</article-title><comment>[accessed 26 May 2024]</comment><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx" id="ir0015">https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx</ext-link><year>2024</year></element-citation></ref><ref id="bb0045"><label>9.</label><element-citation publication-type="other" id="rf0045"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Home Page</article-title><comment>[accessed 26 May 2024]</comment><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sa/en/Pages/default.aspx" id="ir0020">https://www.moh.gov.sa/en/Pages/default.aspx</ext-link><year>2024</year></element-citation></ref><ref id="bb0050"><label>10.</label><element-citation publication-type="other" id="rf0050"><person-group person-group-type="author"><name><surname>SFDA</surname></name></person-group><article-title>Home Page</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.sfda.gov.sa/en" id="ir0025">https://www.sfda.gov.sa/en</ext-link><year>2025</year></element-citation></ref><ref id="bb0055"><label>11.</label><element-citation publication-type="other" id="rf0055"><person-group person-group-type="author"><name><surname>SCFHS</surname></name></person-group><article-title>Home Page</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://scfhs.org.sa/en" id="ir0030">https://scfhs.org.sa/en</ext-link><year>2025</year></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Rasheed</surname><given-names>M.K.</given-names></name><name><surname>Alqasoumi</surname><given-names>A.</given-names></name><name><surname>Hasan</surname><given-names>S.S.</given-names></name><name><surname>Babar</surname><given-names>Z.U.</given-names></name></person-group><article-title>The community pharmacy practice change towards patient-centered care in Saudi Arabia: a qualitative perspective</article-title><source>J Pharm Policy Pract</source><volume>13</volume><year>2020</year><fpage>59</fpage><pub-id pub-id-type="pmid">32944258</pub-id>
</element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>K.S.</given-names></name><name><surname>Petzold</surname><given-names>M.</given-names></name><name><surname>Ewis</surname><given-names>A.A.</given-names></name><name><surname>Alsugoor</surname><given-names>M.H.</given-names></name><name><surname>Saaban</surname><given-names>K.</given-names></name><name><surname>Hussain-Alkhateeb</surname><given-names>L.</given-names></name></person-group><article-title>Public perspective toward extended community pharmacy services in sub-national Saudi Arabia: an online cross-sectional study</article-title><source>PloS One</source><volume>18</volume><issue>10</issue><year>2023</year><object-id pub-id-type="publisher-id">e0280095</object-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>K.S.</given-names></name><name><surname>Petzold</surname><given-names>M.</given-names></name><name><surname>Alsugoor</surname><given-names>M.H.</given-names></name><name><surname>Makeen</surname><given-names>H.A.</given-names></name><name><surname>Al Monif</surname><given-names>K.H.</given-names></name><name><surname>Hussain-Alkhateeb</surname><given-names>L.</given-names></name></person-group><article-title>Community pharmacists&#x02019; perspectives towards automated pharmacy systems and extended community pharmacy services: an online cross-sectional study</article-title><source>Explor Res Clin Soc Pharm</source><volume>12</volume><year>2023</year><object-id pub-id-type="publisher-id">100363</object-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Moshashai</surname><given-names>D.</given-names></name><name><surname>Leber</surname><given-names>A.M.</given-names></name><name><surname>Savage</surname><given-names>J.D.</given-names></name></person-group><article-title>Saudi arabia plans for its economic future: vision 2030, the national transformation plan and saudi fiscal reform</article-title><source>Br J Middle East Stud</source><volume>47</volume><issue>3</issue><year>2020</year><fpage>381</fpage><lpage>401</lpage></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name><surname>Alomi</surname><given-names>Y.A.</given-names></name></person-group><article-title>New pharmacy model for vision 2030 in Saudi Arabia</article-title><source>J Pharm Pract Commun Med</source><volume>3</volume><issue>3</issue><year>2017</year><fpage>194</fpage><lpage>196</lpage></element-citation></ref><ref id="bb0085"><label>17.</label><element-citation publication-type="other" id="rf0085"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Wasfaty</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://wasfaty.sa/" id="ir0035">https://wasfaty.sa/</ext-link><year>2018</year></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>A.</given-names></name></person-group><article-title>Clear and present questions: formulating questions for evidence based practice</article-title><source>Library Hi Tech</source><volume>24</volume><issue>3</issue><year>2006</year><fpage>355</fpage><lpage>368</lpage></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="book" id="rf0095"><person-group person-group-type="author"><name><surname>The EndNote Team</surname></name></person-group><part-title>Endnote. EndNote</part-title><edition>20 ed.</edition><year>2013</year><publisher-name>Clarivate</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Q.N.</given-names></name><name><surname>F&#x000e0;bregues</surname><given-names>S.</given-names></name><name><surname>Bartlett</surname><given-names>G.</given-names></name><etal/></person-group><article-title>He mixed methods appraisal tool (mmat) version 2018 for information professionals and researchers</article-title><source>Educ Inf</source><volume>34</volume><issue>4</issue><year>2018</year><fpage>285</fpage><lpage>291</lpage></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Munn</surname><given-names>Z.</given-names></name><name><surname>Aromataris</surname><given-names>E.</given-names></name><name><surname>Tufanaru</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The development of software to support multiple systematic review types: the joanna briggs institute system for the unified management, assessment and review of information (jbi sumari)</article-title><source>Int J Evid Based Healthc</source><volume>17</volume><issue>1</issue><year>2019</year><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">30239357</pub-id>
</element-citation></ref><ref id="bb0110"><label>22.</label><element-citation publication-type="other" id="rf0110"><person-group person-group-type="author"><name><surname>Jbi sumari</surname></name></person-group><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://sumari.jbi.global/" id="ir0040">https://sumari.jbi.global/</ext-link><year>2025</year></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>J.C.</given-names></name><name><surname>Chong</surname><given-names>W.W.</given-names></name><name><surname>de Almeida Neto</surname><given-names>A.C.</given-names></name><name><surname>Moles</surname><given-names>R.J.</given-names></name><name><surname>Schneider</surname><given-names>C.R.</given-names></name></person-group><article-title>The simulated patient method: design and application in health services research</article-title><source>Res Social Adm Pharm</source><volume>17</volume><issue>12</issue><year>2021</year><fpage>2108</fpage><lpage>2115</lpage><pub-id pub-id-type="pmid">33972178</pub-id>
</element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Green</surname><given-names>E.</given-names></name><name><surname>Hamm</surname><given-names>M.</given-names></name><name><surname>Gowl</surname><given-names>C.</given-names></name><etal/></person-group><article-title>A simulated patient protocol for implementing evidence-based practices in health care delivery</article-title><source>Res Sq</source><year>2023</year></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>S.</given-names></name><name><surname>Al Oum</surname><given-names>L.</given-names></name><name><surname>Hassan</surname><given-names>N.A.</given-names></name></person-group><article-title>A simulated patient study to evaluate community pharmacist assessment, management and advice giving to patients with asthma</article-title><source>J Pharm Policy Pract</source><volume>14</volume><issue>1</issue><year>2021</year><fpage>8</fpage><pub-id pub-id-type="pmid">33436091</pub-id>
</element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Al</surname><given-names>Hassan M.</given-names></name></person-group><article-title>Attitude of community pharmacists towards patient counseling in Saudi Arabia</article-title><source>Internet J Pharmacol</source><volume>9</volume><issue>2</issue><year>2010</year></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Alaqeel</surname><given-names>S.</given-names></name><name><surname>Abanmy</surname><given-names>N.O.</given-names></name></person-group><article-title>Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study</article-title><source>BMC Health Serv Res</source><volume>15</volume><year>2015</year><fpage>557</fpage><pub-id pub-id-type="pmid">26669857</pub-id>
</element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Alfadl</surname><given-names>A.A.</given-names></name><name><surname>Alrasheedy</surname><given-names>A.A.</given-names></name><name><surname>Alhassun</surname><given-names>M.S.</given-names></name></person-group><article-title>Evaluation of medication counseling practice at community pharmacies in qassim region, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>26</volume><issue>2</issue><year>2018</year><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">30166925</pub-id>
</element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>Al Qarni</surname><given-names>H.</given-names></name><name><surname>Alrahbini</surname><given-names>T.</given-names></name><name><surname>AlQarni</surname><given-names>A.M.</given-names></name><name><surname>Alqarni</surname><given-names>A.</given-names></name></person-group><article-title>Community pharmacist counselling practices in the bisha health directorate, Saudi Arabia -simulated patient visits</article-title><source>BMC Health Serv Res</source><volume>20</volume><issue>1</issue><year>2020</year><fpage>745</fpage><pub-id pub-id-type="pmid">32791962</pub-id>
</element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>A.A.</given-names></name><name><surname>Althobaiti</surname><given-names>O.A.</given-names></name><name><surname>Althobaiti</surname><given-names>A.E.</given-names></name><name><surname>Althomali</surname><given-names>A.O.</given-names></name><name><surname>Yossef</surname><given-names>O.M.</given-names></name></person-group><article-title>Community pharmacists&#x02019; response to acute back pain: a simulated patient study in western region, Saudi Arabia</article-title><source>GSC Biol Pharm Sci</source><volume>2</volume><issue>2</issue><year>2018</year><fpage>025</fpage><lpage>032</lpage></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>H.M.</given-names></name></person-group><article-title>Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia</article-title><source>J Int Med Res</source><volume>47</volume><issue>5</issue><year>2019</year><fpage>2018</fpage><lpage>2025</lpage><pub-id pub-id-type="pmid">30885078</pub-id>
</element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name><surname>Malebari</surname><given-names>A.M.</given-names></name><name><surname>Khayyat</surname><given-names>A.N.</given-names></name><name><surname>Mahdali</surname><given-names>R.A.</given-names></name><name><surname>Alamoudi</surname><given-names>J.S.</given-names></name><name><surname>Alsayed</surname><given-names>B.Y.</given-names></name><name><surname>Alrasheed</surname><given-names>S.A.</given-names></name></person-group><article-title>Evaluation of the community pharmacists&#x02019; performance in the screening of non-steroidal anti-inflmmatory drugs risks in Saudi Arabia</article-title><source>Saudi Med J</source><volume>41</volume><issue>8</issue><year>2020</year><fpage>849</fpage><lpage>857</lpage><pub-id pub-id-type="pmid">32789426</pub-id>
</element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>T.M.</given-names></name><name><surname>Hadi</surname><given-names>M.A.</given-names></name></person-group><article-title>Preceptors&#x02019; use of hand-held devices and use of drug information resources in al-ahsa, Saudi Arabia</article-title><source>Curr Pharm Teach Learn</source><volume>6</volume><issue>2</issue><year>2014</year><fpage>284</fpage><lpage>288</lpage></element-citation></ref><ref id="bb0170"><label>34.</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name><surname>Al Qahtani IATAW</surname></name></person-group><article-title>Competency of metered dose inhaler use among saudi community pharmacists: a simulation methods study</article-title><source>RRJPPS</source><volume>4</volume><issue>2</issue><year>2015</year></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name><surname>Adnan</surname><given-names>M.</given-names></name><name><surname>Karim</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Al-Wabel</surname><given-names>N.A.</given-names></name></person-group><article-title>Comparative evaluation of metered-dose inhaler technique demonstration among community pharmacists in al qassim and al-ahsa region, Saudi-Arabia</article-title><source>Saudi Pharm J</source><volume>23</volume><issue>2</issue><year>2015</year><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">25972732</pub-id>
</element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name><surname>Alotaibi</surname><given-names>H.S.</given-names></name><name><surname>Shivanandappa</surname><given-names>T.B.</given-names></name><name><surname>Nagarethinam</surname><given-names>S.</given-names></name></person-group><article-title>Contribution of community pharmacists in educating the asthma patients</article-title><source>Saudi Pharm J</source><volume>24</volume><issue>6</issue><year>2016</year><fpage>685</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">27829811</pub-id>
</element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name><surname>Wajid</surname><given-names>S.A.A.</given-names></name><name><surname>Al-Arif</surname><given-names>Mohamed N.</given-names></name><name><surname>Nomay</surname><given-names>H.</given-names></name><name><surname>Al Mousa</surname><given-names>Y.</given-names></name><name><surname>Babelghaith</surname><given-names>S.</given-names></name></person-group><article-title>Knowledge and perception of community pharmacists&#x02019; towards generic medicines in Saudi Arabia</article-title><source>Biomed Res</source><volume>26</volume><issue>4</issue><year>2015</year><fpage>800</fpage><lpage>806</lpage></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name><surname>Albadr</surname><given-names>Y.</given-names></name><name><surname>Khan</surname><given-names>T.M.</given-names></name></person-group><article-title>Factors influencing community pharmacist decision to dispense generic or branded medicines; eastern province, alahsa, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>23</volume><issue>2</issue><year>2015</year><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">25972733</pub-id>
</element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name><surname>Alkhuzaee</surname><given-names>F.S.</given-names></name><name><surname>Almalki</surname><given-names>H.M.</given-names></name><name><surname>Attar</surname><given-names>A.Y.</given-names></name><etal/></person-group><article-title>Evaluating community pharmacists&#x02019; perspectives and practices concerning generic medicines substitution in Saudi Arabia: a cross-sectional study</article-title><source>Health Policy</source><volume>120</volume><issue>12</issue><year>2016</year><fpage>1412</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">28228231</pub-id>
</element-citation></ref><ref id="bb0200"><label>40</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>T.M.</given-names></name><name><surname>Ibrahim</surname><given-names>Y.</given-names></name></person-group><article-title>A qualitative exploration of the non-prescription sale of drugs and incidence of adverse events in community pharmacy settings in the eastern province of the Kingdom of Saudi Arabia</article-title><source>Eur J Hosp Pharm</source><volume>20</volume><issue>1</issue><year>2013</year><fpage>26</fpage><lpage>31</lpage></element-citation></ref><ref id="bb0205"><label>41</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name><surname>Al-Mohamadi</surname><given-names>A.</given-names></name><name><surname>Badr</surname><given-names>A.</given-names></name><name><surname>Bin Mahfouz</surname><given-names>L.</given-names></name><name><surname>Samargandi</surname><given-names>D.</given-names></name><name><surname>Al</surname><given-names>Ahdal A.</given-names></name></person-group><article-title>Dispensing medications without prescription at saudi community pharmacy: extent and perception</article-title><source>Saudi Pharm J</source><volume>21</volume><issue>1</issue><year>2013</year><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">23960815</pub-id>
</element-citation></ref><ref id="bb0210"><label>42</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name><surname>Al Rukban</surname><given-names>M.R.</given-names></name><name><surname>M.</surname></name></person-group><article-title>Pharmacist&#x02019;s knowledge, attitude and practices towards written prescription in dispensing and substitution of drugs in Riyadh. Majmaah</article-title><source>J Health Sci</source><volume>2</volume><issue>2</issue><year>2014</year></element-citation></ref><ref id="bb0215"><label>43</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name><surname>Alrwisan</surname><given-names>A.A.</given-names></name><name><surname>Alshammari</surname><given-names>T.M.</given-names></name><name><surname>Tahir</surname><given-names>K.W.</given-names></name><name><surname>Aleissa</surname><given-names>F.M.</given-names></name><name><surname>Aljadhey</surname><given-names>H.S.</given-names></name></person-group><article-title>Community pharmacists&#x02019; knowledge of isotretinoin safety</article-title><source>Saudi Med J</source><volume>35</volume><issue>1</issue><year>2014</year><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">24445895</pub-id>
</element-citation></ref><ref id="bb0220"><label>44</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.E.</given-names></name><name><surname>P.</surname></name></person-group><article-title>A qualitative assessment of community pharmacists views about the non-prescription sale of citalopram for the management of premature ejaculation in eastern region, alahsa, Saudi Arabia</article-title><source>JPHSR</source><volume>6</volume><year>2015</year><fpage>27</fpage><lpage>31</lpage></element-citation></ref><ref id="bb0225"><label>45</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name><surname>Suleiman</surname><given-names>A.K.</given-names></name><name><surname>Khan</surname><given-names>T.M.</given-names></name><name><surname>Emeka</surname><given-names>P.M.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Mansoor</surname><given-names>S.M.</given-names></name></person-group><article-title>The public purchase of aphrodisiac products without prescriptions in the alahsa region of ksa</article-title><source>J Taibah Univ Med Sci</source><volume>11</volume><issue>5</issue><year>2016</year><fpage>413</fpage><lpage>417</lpage></element-citation></ref><ref id="bb0230"><label>46</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name><surname>Bahnassi</surname><given-names>A.</given-names></name></person-group><article-title>Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia</article-title><source>Int J Pharm Pract</source><volume>24</volume><issue>2</issue><year>2016</year><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">26383607</pub-id>
</element-citation></ref><ref id="bb0235"><label>47</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name><surname>Kashour</surname><given-names>T.S.</given-names></name><name><surname>Joury</surname><given-names>A.</given-names></name><name><surname>Alotaibi</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Quality of assessment and counselling offered by community pharmacists and medication sale without prescription to patients presenting with acute cardiac symptoms: a simulated client study</article-title><source>Eur J Clin Pharmacol</source><volume>72</volume><issue>3</issue><year>2016</year><fpage>321</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">26592495</pub-id>
</element-citation></ref><ref id="bb0240"><label>48</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name><surname>Alshammari</surname><given-names>T.M.</given-names></name><name><surname>Alhindi</surname><given-names>S.A.</given-names></name><name><surname>Alrashdi</surname><given-names>A.M.</given-names></name><name><surname>Benmerzouga</surname><given-names>I.</given-names></name><name><surname>Aljofan</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacy malpractice: the rate and prevalence of dispensing high-risk prescription-only medications at community pharmacies in Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>25</volume><issue>5</issue><year>2017</year><fpage>709</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">28725143</pub-id>
</element-citation></ref><ref id="bb0245"><label>49</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name><surname>Bin Abdulhak</surname><given-names>A.A.</given-names></name><name><surname>Altannir</surname><given-names>M.A.</given-names></name><name><surname>Almansor</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study</article-title><source>BMC Public Health</source><volume>11</volume><year>2011</year><fpage>538</fpage><pub-id pub-id-type="pmid">21736711</pub-id>
</element-citation></ref><ref id="bb0250"><label>50</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name><surname>Emeka</surname><given-names>P.A.O.</given-names></name><name><surname>M; Khan, T.</surname></name></person-group><article-title>A qualitative study exploring role of community pharmacy in the irrational use and purchase of non&#x000ac;prescription antibiotics in al ahsa</article-title><source>Eur J Gen Med</source><volume>9</volume><issue>4</issue><year>2012</year><fpage>230</fpage><lpage>234</lpage></element-citation></ref><ref id="bb0255"><label>51</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name><surname>Hadi</surname><given-names>M.A.</given-names></name><name><surname>Karami</surname><given-names>N.A.</given-names></name><name><surname>Al-Muwalid</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>Community pharmacists&#x02019; knowledge, attitude, and practices towards dispensing antibiotics without prescription (dawp): a cross-sectional survey in Makkah province, Saudi Arabia</article-title><source>Int J Infect Dis</source><volume>47</volume><year>2016</year><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">27343987</pub-id>
</element-citation></ref><ref id="bb0260"><label>52</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name><surname>Al</surname><given-names>Akhali K.</given-names></name></person-group><article-title>Attitudes and perceptions of community pharmacists to antibiotic dispensing and microbial resistance. A study in Asir region, Kingdom of Saudi Arabia</article-title><source>KKU J Med Sci</source><volume>1</volume><year>2016</year></element-citation></ref><ref id="bb0265"><label>53</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>M.A.D.</given-names></name><name><surname>Sheikh</surname><given-names>A.</given-names></name><name><surname>Aljadhey</surname><given-names>H.</given-names></name></person-group><article-title>Community pharmacists perspectives about reasons behind antibiotics dispensing without prescription: a qualitative study</article-title><source>Biomed Res</source><volume>29</volume><issue>21</issue><year>2018</year><fpage>3792</fpage><lpage>3796</lpage></element-citation></ref><ref id="bb0270"><label>54</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name><surname>Alhomoud</surname><given-names>F.</given-names></name><name><surname>Almahasnah</surname><given-names>R.</given-names></name><name><surname>Alhomoud</surname><given-names>F.K.</given-names></name></person-group><article-title>&#x0201c;You could lose when you misuse&#x0201d; - factors affecting over-the-counter sale of antibiotics in community pharmacies in Saudi Arabia: a qualitative study</article-title><source>BMC Health Serv Res</source><volume>18</volume><issue>1</issue><year>2018</year><fpage>915</fpage><pub-id pub-id-type="pmid">30509267</pub-id>
</element-citation></ref><ref id="bb0275"><label>55</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name><surname>Alrefaei</surname><given-names>A.</given-names></name><name><surname>Asiri</surname><given-names>M.</given-names></name><name><surname>Maashi</surname><given-names>H.</given-names></name><name><surname>Bahri</surname><given-names>Q.</given-names></name><name><surname>Sultan</surname><given-names>H.</given-names></name><name><surname>Addarbi</surname><given-names>Y.</given-names></name></person-group><article-title>Knowledge of pharmacists about antimicrobial drugs, and their perceptions and practices regarding antimicrobial stewardship: a cross-sectional study in Saudi Arabia</article-title><source>Int J Med Dev Countries</source><year>2019</year><fpage>335</fpage><lpage>339</lpage></element-citation></ref><ref id="bb0280"><label>56</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name><surname>Alrasheedy</surname><given-names>A.A.</given-names></name><name><surname>Alsalloum</surname><given-names>M.A.</given-names></name><name><surname>Almuqbil</surname><given-names>F.A.</given-names></name><etal/></person-group><article-title>The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia</article-title><source>Expert Rev Anti Infect Ther</source><volume>18</volume><issue>1</issue><year>2020</year><fpage>87</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">31834825</pub-id>
</element-citation></ref><ref id="bb0285"><label>57</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name><surname>Al-Tannir</surname><given-names>M.</given-names></name><name><surname>Altannir</surname><given-names>Y.</given-names></name><name><surname>Altannir</surname><given-names>M.</given-names></name><name><surname>AlFayyad</surname><given-names>I.</given-names></name></person-group><article-title>Community pharmacy sales of non-prescribed antibiotics in Riyadh, Saudi Arabia: a simulated patient study</article-title><source>Int J Clin Pharmacol</source><volume>42</volume><issue>2</issue><year>2020</year><fpage>341</fpage><lpage>346</lpage></element-citation></ref><ref id="bb0290"><label>58</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name><surname>AlRukban</surname><given-names>M.</given-names></name><name><surname>AlRuthia</surname><given-names>Y.</given-names></name><name><surname>Almasaoud</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Community pharmacists&#x02019; views of the enforced antibiotics dispensing law and its impact on oral antibiotics sales in Saudi Arabia</article-title><source>Risk Manag Healthc Policy</source><volume>13</volume><year>2020</year><fpage>2899</fpage><lpage>2907</lpage><pub-id pub-id-type="pmid">33335435</pub-id>
</element-citation></ref><ref id="bb0295"><label>59</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name><surname>Alkharfy</surname><given-names>K.</given-names></name></person-group><article-title>Community pharmacists&#x02019; knowledge, attitudes and practices towards herbal remedies in Riyadh, Saudi Arabia</article-title><source>EMHJ-East Mediterr Health J</source><volume>16</volume><issue>9</issue><year>2010</year><fpage>988</fpage><lpage>993</lpage></element-citation></ref><ref id="bb0300"><label>60</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name><surname>Al Rukban</surname><given-names>M.K.</given-names></name></person-group><article-title>Adherence to otc directory - the perception of community pharmacists in Saudi Arabia</article-title><source>J Ayub Med Coll Abbottabad</source><volume>24</volume><issue>3&#x02013;4</issue><year>2012</year></element-citation></ref><ref id="bb0305"><label>61</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>21</volume><issue>4</issue><year>2013</year><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">24227954</pub-id>
</element-citation></ref><ref id="bb0310"><label>62</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name><surname>Alshahrani</surname><given-names>S.M.</given-names></name></person-group><article-title>Assessment of knowledge, attitudes, and practice of community pharmacists regarding weight reduction agents and supplements in aseer region, Saudi Arabia</article-title><source>Risk Manag Healthc Policy</source><volume>13</volume><year>2020</year><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">32368165</pub-id>
</element-citation></ref><ref id="bb0315"><label>63</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name><surname>Alsayari</surname><given-names>A.</given-names></name><name><surname>Almghaslah</surname><given-names>D.</given-names></name><name><surname>Khaled</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Community pharmacists&#x02019; knowledge, attitudes, and practice of herbal medicines in Asir region, Kingdom of Saudi Arabia</article-title><source>Evid Based Complement Alternat Med</source><volume>2018</volume><year>2018</year><fpage>1568139</fpage><pub-id pub-id-type="pmid">30228824</pub-id>
</element-citation></ref><ref id="bb0320"><label>64</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>N.J.</given-names></name><name><surname>Khan</surname><given-names>M.F.</given-names></name></person-group><article-title>Community pharmacists&#x02019; knowledge, attitudes and practices towards the use of herbal remedies</article-title><source>J Pharm Res Int</source><year>2019</year><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="bb0325"><label>65</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name><surname>Ghosn</surname><given-names>S.A.A.</given-names></name><name><surname>Addison</surname><given-names>B.</given-names></name><name><surname>Ali</surname><given-names>M.D.</given-names></name></person-group><article-title>Community pharmacist&#x02019;s knowledge, attitude, and practices towards vitamin supplements in al-Khobar region, Saudi Arabia: a descriptive cross-sectional study</article-title><source>J Pharm Bioallied Sci</source><volume>11</volume><year>2019</year><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">31619915</pub-id>
</element-citation></ref><ref id="bb0330"><label>66</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name><surname>Alhossan</surname><given-names>A.</given-names></name><name><surname>Alrabiah</surname><given-names>Z.</given-names></name><name><surname>Alghadeer</surname><given-names>S.</given-names></name><name><surname>Bablghaith</surname><given-names>S.</given-names></name><name><surname>Wajid</surname><given-names>S.</given-names></name><name><surname>Al-Arifi</surname><given-names>M.</given-names></name></person-group><article-title>Attitude and knowledge of saudi community pharmacists towards use of proton pump inhibitors</article-title><source>Saudi Pharm J</source><volume>27</volume><issue>2</issue><year>2019</year><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">30766433</pub-id>
</element-citation></ref><ref id="bb0335"><label>67</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name><surname>Aloudah</surname><given-names>N.</given-names></name><name><surname>Alhumsi</surname><given-names>A.</given-names></name><name><surname>Alobeid</surname><given-names>N.</given-names></name><name><surname>Aboheimed</surname><given-names>N.</given-names></name><name><surname>Aboheimed</surname><given-names>H.</given-names></name><name><surname>Aboheimed</surname><given-names>G.</given-names></name></person-group><article-title>Factors impeding the supply of over-the-counter medications according to evidence-based practice: a mixed-methods study</article-title><source>PloS One</source><volume>15</volume><issue>11</issue><year>2020</year><object-id pub-id-type="publisher-id">e0240913</object-id></element-citation></ref><ref id="bb0340"><label>68</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name><surname>Kurban</surname><given-names>N.A.</given-names></name><name><surname>Altwaim</surname><given-names>S.A.</given-names></name><name><surname>Altayeb</surname><given-names>G.A.</given-names></name><name><surname>Somali</surname><given-names>N.A.</given-names></name><name><surname>Almehmady</surname><given-names>A.M.</given-names></name><name><surname>Alharbi</surname><given-names>W.S.</given-names></name></person-group><article-title>Cosmeceutical awareness among community pharmacists in Jeddah, Saudi Arabia: the case of sunscreens and moisturizers</article-title><source>J Cosmet Dermatol</source><volume>19</volume><issue>9</issue><year>2020</year><fpage>2394</fpage><lpage>2400</lpage><pub-id pub-id-type="pmid">32578358</pub-id>
</element-citation></ref><ref id="bb0345"><label>69</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name><surname>Alshahrani</surname><given-names>A.</given-names></name></person-group><article-title>Knowledge, attitudes, and practice of community pharmacists towards providing counseling on vitamins, and nutritional supplements in Saudi Arabia</article-title><source>AIMS Public Health</source><volume>7</volume><issue>3</issue><year>2020</year><fpage>697</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">32968687</pub-id>
</element-citation></ref><ref id="bb0350"><label>70</label><element-citation publication-type="journal" id="rf0350"><person-group person-group-type="author"><name><surname>Al</surname><given-names>Akhali K.</given-names></name></person-group><article-title>Assessment of self-medication pattern of pharmacist in Asir region, Saudi Arabia</article-title><source>Bull Pharm Sci</source><volume>39</volume><year>2016</year><fpage>87</fpage><lpage>93</lpage></element-citation></ref><ref id="bb0355"><label>71</label><element-citation publication-type="journal" id="rf0355"><person-group person-group-type="author"><name><surname>Bawazir</surname><given-names>O.A.</given-names></name></person-group><article-title>Knowledge and attitudes of pharmacists regarding oral healthcare and oral hygiene products in Riyadh, Saudi Arabia</article-title><source>J Int Oral Health</source><volume>6</volume><issue>6</issue><year>2014</year><fpage>10</fpage><pub-id pub-id-type="pmid">25628475</pub-id>
</element-citation></ref><ref id="bb0360"><label>72</label><element-citation publication-type="journal" id="rf0360"><person-group person-group-type="author"><name><surname>Al-Saleh</surname><given-names>H.</given-names></name><name><surname>Al-Houtan</surname><given-names>T.</given-names></name><name><surname>Al-Odaill</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Role of community pharmacists in providing oral health advice in the eastern province of Saudi Arabia</article-title><source>Saudi Dent J</source><volume>29</volume><issue>3</issue><year>2017</year><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">28725130</pub-id>
</element-citation></ref><ref id="bb0365"><label>73</label><element-citation publication-type="journal" id="rf0365"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Community pharmacists&#x02019; attitudes toward dispensing errors at community pharmacy setting in Central Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>22</volume><issue>3</issue><year>2014</year><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">25061403</pub-id>
</element-citation></ref><ref id="bb0370"><label>74</label><element-citation publication-type="journal" id="rf0370"><person-group person-group-type="author"><name><surname>Alrabiah</surname><given-names>Z.</given-names></name><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name><name><surname>Alghadeer</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Knowledge of community pharmacists about the risks of medication use during pregnancy in central region of Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>25</volume><issue>7</issue><year>2017</year><fpage>1093</fpage><lpage>1096</lpage><pub-id pub-id-type="pmid">29158721</pub-id>
</element-citation></ref><ref id="bb0375"><label>75</label><element-citation publication-type="journal" id="rf0375"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>F.O.</given-names></name><name><surname>Alwafi</surname><given-names>H.A.</given-names></name><name><surname>Alshaghab</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Prevalence of prescription errors in general practice in Jeddah, Saudi Arabia</article-title><source>Med Teach</source><volume>40</volume><issue>sup1</issue><year>2018</year><fpage>S22</fpage><lpage>S29</lpage><pub-id pub-id-type="pmid">29703122</pub-id>
</element-citation></ref><ref id="bb0380"><label>76</label><element-citation publication-type="journal" id="rf0380"><person-group person-group-type="author"><name><surname>Alrabiah</surname><given-names>Z.</given-names></name><name><surname>Alhossan</surname><given-names>A.</given-names></name><name><surname>Alghadeer</surname><given-names>S.M.</given-names></name><name><surname>Wajid</surname><given-names>S.</given-names></name><name><surname>Babelghaith</surname><given-names>S.D.</given-names></name><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Evaluation of community pharmacists&#x02019; knowledge about drug-drug interaction in Central Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>27</volume><issue>4</issue><year>2019</year><fpage>463</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">31061613</pub-id>
</element-citation></ref><ref id="bb0385"><label>77</label><element-citation publication-type="journal" id="rf0385"><person-group person-group-type="author"><name><surname>Mobrad</surname><given-names>A.M.</given-names></name><name><surname>Alghadeer</surname><given-names>S.</given-names></name><name><surname>Syed</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Knowledge, attitudes, and beliefs regarding drug abuse and misuse among community pharmacists in Saudi Arabia</article-title><source>Int J Environ Res Public Health</source><volume>17</volume><issue>4</issue><year>2020</year></element-citation></ref><ref id="bb0390"><label>78</label><element-citation publication-type="journal" id="rf0390"><person-group person-group-type="author"><name><surname>Alahdal</surname><given-names>A.B.A.</given-names></name></person-group><article-title>Evaluation of the role of pharmacists in community setting in Jeddah, Saudi Arabia</article-title><source>Life Sci</source><volume>13</volume><issue>2</issue><year>2016</year></element-citation></ref><ref id="bb0395"><label>79</label><element-citation publication-type="journal" id="rf0395"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>N.</given-names></name><name><surname>Al-Wahibi</surname><given-names>N.</given-names></name></person-group><article-title>Knowledge attitude and practice towards pharmaceutical care in community pharmacy in Saudi Arabia</article-title><source>Br J Med Med Res</source><volume>15</volume><issue>9</issue><year>2016</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bb0400"><label>80</label><element-citation publication-type="journal" id="rf0400"><person-group person-group-type="author"><name><surname>Gillani</surname><given-names>S.W.</given-names></name><name><surname>Rahman</surname><given-names>Sau</given-names></name><name><surname>Mohammad Abdul</surname><given-names>M.I.</given-names></name><name><surname>Sulaiman</surname><given-names>S.A.S.</given-names></name></person-group><article-title>Assessment of community pharmacists&#x02019; perceptions of healthcare services in Saudi Arabia</article-title><source>J Pharm Health Serv Res</source><volume>8</volume><issue>4</issue><year>2017</year><fpage>269</fpage><lpage>274</lpage></element-citation></ref><ref id="bb0405"><label>81</label><element-citation publication-type="journal" id="rf0405"><person-group person-group-type="author"><name><surname>Balkhi</surname><given-names>B.</given-names></name><name><surname>Aljadhey</surname><given-names>H.</given-names></name><name><surname>Mahmoud</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Readiness and willingness to provide immunization services: a survey of community pharmacists in Riyadh, Saudi Arabia</article-title><source>Saf Health</source><volume>4</volume><issue>1</issue><year>2018</year></element-citation></ref><ref id="bb0410"><label>82.</label><element-citation publication-type="journal" id="rf0410"><person-group person-group-type="author"><name><surname>Alshahrani</surname><given-names>A.</given-names></name></person-group><article-title>Readiness of community pharmacists to play a supportive and advocacy role in the fight against corona virus disease</article-title><source>Risk Manag Healthc Policy</source><volume>13</volume><year>2020</year><fpage>3121</fpage><lpage>3133</lpage><pub-id pub-id-type="pmid">33380851</pub-id>
</element-citation></ref><ref id="bb0415"><label>83</label><element-citation publication-type="journal" id="rf0415"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>H.M.J.</given-names></name></person-group><article-title>Community pharmacy services and preparedness during covid-19 outbreak in madinah, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>28</volume><issue>11</issue><year>2020</year><fpage>1402</fpage><lpage>1407</lpage><pub-id pub-id-type="pmid">32958992</pub-id>
</element-citation></ref><ref id="bb0420"><label>84</label><element-citation publication-type="journal" id="rf0420"><person-group person-group-type="author"><name><surname>Suleiman</surname><given-names>A.K.</given-names></name></person-group><article-title>Stress and job satisfaction among pharmacists in Riyadh, Saudi Arabia</article-title><source>Saudi J Med Med Sci</source><volume>3</volume><issue>3</issue><year>2015</year><fpage>213</fpage><lpage>219</lpage></element-citation></ref><ref id="bb0425"><label>85</label><element-citation publication-type="journal" id="rf0425"><person-group person-group-type="author"><name><surname>Zahrani</surname><given-names>F.</given-names></name><name><surname>Ghamdi</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>R.</given-names></name></person-group><article-title>Job satisfaction among retail pharmacists in eastern region of Saudi Arabia</article-title><source>J Pharm Res Int</source><volume>19</volume><issue>5</issue><year>2017</year><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="bb0430"><label>86</label><element-citation publication-type="journal" id="rf0430"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>T.M.</given-names></name></person-group><article-title>Community pharmacists&#x02019; knowledge and perceptions about adverse drug reactions and barriers towards their reporting in eastern region, alahsa, Saudi Arabia</article-title><source>Ther Adv Drug Saf</source><volume>4</volume><issue>2</issue><year>2013</year><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">25083250</pub-id>
</element-citation></ref><ref id="bb0435"><label>87</label><element-citation publication-type="journal" id="rf0435"><person-group person-group-type="author"><name><surname>Al-Hazmi</surname><given-names>N.N.</given-names></name><name><surname>Il</surname><given-names>N.</given-names></name></person-group><article-title>A study of community pharmacists&#x02019; awareness and contributions to adverse drug reactions (adrs) reporting systems in the Makkah, Kingdom of Saudi Arabia (ksa)</article-title><source>J Clin Trials</source><volume>03</volume><issue>01</issue><year>2013</year></element-citation></ref><ref id="bb0440"><label>88</label><element-citation publication-type="journal" id="rf0440"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>M.A.</given-names></name><name><surname>Alsowaida</surname><given-names>Y.</given-names></name><name><surname>Alshammari</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Community pharmacists&#x02019; knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>22</volume><issue>5</issue><year>2014</year><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">25473329</pub-id>
</element-citation></ref><ref id="bb0445"><label>89</label><element-citation publication-type="journal" id="rf0445"><person-group person-group-type="author"><name><surname>Rabba</surname><given-names>A.A.</given-names></name><name><surname>M.</surname></name></person-group><article-title>Pharmacovigilance study: exploring the role of community pharmacists in adverse drug reactions reporting in alkharj city, Saudi Arabia</article-title><source>Lat Am J Pharm</source><volume>34</volume><issue>5</issue><year>2015</year><fpage>901</fpage><lpage>906</lpage></element-citation></ref><ref id="bb0450"><label>90</label><element-citation publication-type="journal" id="rf0450"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.D.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Hassan</surname><given-names>Y.A.M.</given-names></name><name><surname>Ghosn</surname><given-names>S.A.</given-names></name><name><surname>Banu</surname><given-names>N.</given-names></name><name><surname>Alzahrani</surname><given-names>M.G.</given-names></name></person-group><article-title>Community pharmacist&#x02019;s knowledge, practice and barrier towards reporting of adverse drug reactions in Dammam, Saudi Arabia: a cross-sectional survey based study</article-title><source>J Young Pharm</source><volume>12</volume><issue>1</issue><year>2020</year><fpage>81</fpage><lpage>85</lpage></element-citation></ref><ref id="bb0455"><label>91</label><element-citation publication-type="journal" id="rf0455"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Community pharmacist perception and attitude toward ethical issues at community pharmacy setting in Central Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>22</volume><issue>4</issue><year>2014</year><fpage>315</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">25161375</pub-id>
</element-citation></ref><ref id="bb0460"><label>92</label><element-citation publication-type="journal" id="rf0460"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>H.M.J.</given-names></name></person-group><article-title>Privacy level in private community pharmacies in Saudi Arabia: a simulated client survey</article-title><source>Pharmacol Pharm</source><volume>10</volume><issue>10</issue><year>2019</year><fpage>445</fpage><lpage>455</lpage></element-citation></ref><ref id="bb0465"><label>93</label><element-citation publication-type="journal" id="rf0465"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>H.M.J.</given-names></name><name><surname>Abdalla</surname><given-names>A.M.E.</given-names></name></person-group><article-title>Do community pharmacies in Saudi Arabia provide medication-related information to nonbuyers? A mysterious shopper survey</article-title><source>Pharmacol Pharm</source><volume>10</volume><issue>04</issue><year>2019</year><fpage>169</fpage><lpage>176</lpage></element-citation></ref><ref id="bb0470"><label>94</label><element-citation publication-type="journal" id="rf0470"><person-group person-group-type="author"><name><surname>Alotaibi</surname><given-names>H.S.</given-names></name><name><surname>Abdelkarim</surname><given-names>M.A.</given-names></name></person-group><article-title>Consumers&#x02019; perceptions on the contribution of community pharmacists in the dispensing process at dawadmi</article-title><source>Saudi Pharm J</source><volume>23</volume><issue>3</issue><year>2015</year><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">26106270</pub-id>
</element-citation></ref><ref id="bb0475"><label>95</label><element-citation publication-type="journal" id="rf0475"><person-group person-group-type="author"><name><surname>Alosaimi</surname><given-names>F.D.</given-names></name><name><surname>Alruwais</surname><given-names>F.S.</given-names></name><name><surname>Alanazi</surname><given-names>F.A.</given-names></name><name><surname>Alabidi</surname><given-names>G.A.</given-names></name><name><surname>Aljomah</surname><given-names>N.A.</given-names></name><name><surname>Alsalameh</surname><given-names>N.S.</given-names></name></person-group><article-title>Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia</article-title><source>Neurosciences (Riyadh)</source><volume>21</volume><issue>4</issue><year>2016</year><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">27744463</pub-id>
</element-citation></ref><ref id="bb0480"><label>96</label><element-citation publication-type="journal" id="rf0480"><person-group person-group-type="author"><name><surname>Al Aqeel</surname><given-names>S.</given-names></name><name><surname>Hiligsmann</surname><given-names>M.</given-names></name></person-group><article-title>Applying a best-worst scaling methodology to prioritise important attributes of counselling from community pharmacy users&#x02019; perspective, Saudi Arabia</article-title><source>J Pharm Health Serv Res</source><volume>9</volume><issue>2</issue><year>2018</year><fpage>153</fpage><lpage>159</lpage></element-citation></ref><ref id="bb0485"><label>97</label><element-citation publication-type="journal" id="rf0485"><person-group person-group-type="author"><name><surname>Almubark</surname><given-names>R.A.</given-names></name><name><surname>Aljadani</surname><given-names>R.H.</given-names></name><name><surname>Alqahtani</surname><given-names>A.S.</given-names></name><name><surname>Alshammari</surname><given-names>T.M.</given-names></name><name><surname>BinDhim</surname><given-names>N.F.</given-names></name></person-group><article-title>National cross-sectional study of community-based adverse drug reactions in Saudi Arabia</article-title><source>Drugs Real World Outcomes</source><volume>7</volume><issue>2</issue><year>2020</year><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">32215839</pub-id>
</element-citation></ref><ref id="bb0490"><label>98</label><element-citation publication-type="journal" id="rf0490"><person-group person-group-type="author"><name><surname>AlShayban</surname><given-names>D.M.</given-names></name><name><surname>Naqvi</surname><given-names>A.A.</given-names></name><name><surname>Alhumaid</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Association of disease knowledge and medication adherence among out-patients with type 2 diabetes mellitus in Khobar, Saudi Arabia</article-title><source>Front Pharmacol</source><volume>11</volume><year>2020</year><fpage>60</fpage><pub-id pub-id-type="pmid">32153397</pub-id>
</element-citation></ref><ref id="bb0495"><label>99</label><element-citation publication-type="journal" id="rf0495"><person-group person-group-type="author"><name><surname>Suleiman</surname><given-names>A.K.</given-names></name></person-group><article-title>Self-medication and the advisory role of pharmacists in Riyadh, Saudi Arabia</article-title><source>Arch Pharm Pract</source><volume>4</volume><issue>4</issue><year>2013</year><fpage>180</fpage><lpage>185</lpage></element-citation></ref><ref id="bb0500"><label>100</label><element-citation publication-type="journal" id="rf0500"><person-group person-group-type="author"><name><surname>Aljadhey</surname><given-names>H.</given-names></name><name><surname>Assiri</surname><given-names>G.A.</given-names></name><name><surname>Mahmoud</surname><given-names>M.A.</given-names></name><name><surname>Al-Aqeel</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>M.</given-names></name></person-group><article-title>Self-medication in Central Saudi Arabia. Community pharmacy consumers&#x02019; perspectives</article-title><source>Saudi Med J</source><volume>36</volume><issue>3</issue><year>2015</year><fpage>328</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">25737176</pub-id>
</element-citation></ref><ref id="bb0505"><label>101</label><element-citation publication-type="journal" id="rf0505"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>M.</given-names></name><name><surname>Alanazi</surname><given-names>A.</given-names></name><name><surname>Moin</surname><given-names>A.</given-names></name></person-group><article-title>Consumers&#x02019; awareness, attitude and associated factors towards self-medication in hail, Saudi Arabia</article-title><source>PloS One</source><volume>15</volume><issue>4</issue><year>2020</year><object-id pub-id-type="publisher-id">e0232322</object-id></element-citation></ref><ref id="bb0510"><label>102</label><element-citation publication-type="journal" id="rf0510"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>K.A.</given-names></name></person-group><article-title>Prevalence of self-medication among urban population participating community pharmacies</article-title><source>Asian J Pharm (AJP)</source><volume>14</volume><issue>03</issue><year>2020</year></element-citation></ref><ref id="bb0515"><label>103</label><element-citation publication-type="journal" id="rf0515"><person-group person-group-type="author"><name><surname>Almansour</surname><given-names>H.A.</given-names></name><name><surname>Aloudah</surname><given-names>N.M.</given-names></name><name><surname>Alhawassi</surname><given-names>T.M.</given-names></name><name><surname>Chaar</surname><given-names>B.</given-names></name><name><surname>Krass</surname><given-names>I.</given-names></name><name><surname>Saini</surname><given-names>B.</given-names></name></person-group><article-title>Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: a qualitative analysis</article-title><source>Saudi Pharm J</source><volume>28</volume><issue>5</issue><year>2020</year><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">32435133</pub-id>
</element-citation></ref><ref id="bb0520"><label>104</label><element-citation publication-type="journal" id="rf0520"><person-group person-group-type="author"><name><surname>Alzayer</surname><given-names>R.</given-names></name><name><surname>Almansour</surname><given-names>H.A.</given-names></name><name><surname>Basheti</surname><given-names>I.</given-names></name><name><surname>Chaar</surname><given-names>B.</given-names></name><name><surname>Al Aloola</surname><given-names>N.</given-names></name><name><surname>Saini</surname><given-names>B.</given-names></name></person-group><article-title>Asthma patients in Saudi Arabia - preferences, health beliefs and experiences that shape asthma management</article-title><source>Ethn Health</source><year>2020</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="bb0525"><label>105</label><element-citation publication-type="journal" id="rf0525"><person-group person-group-type="author"><name><surname>Al Aloola</surname><given-names>N.</given-names></name><name><surname>Alsaif</surname><given-names>R.</given-names></name><name><surname>Alhabib</surname><given-names>H.</given-names></name><name><surname>Alhossan</surname><given-names>A.</given-names></name></person-group><article-title>Community needs and preferences for community pharmacy immunization services</article-title><source>Vaccine</source><volume>38</volume><issue>32</issue><year>2020</year><fpage>5009</fpage><lpage>5014</lpage><pub-id pub-id-type="pmid">32540273</pub-id>
</element-citation></ref><ref id="bb0530"><label>106</label><element-citation publication-type="journal" id="rf0530"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Patients&#x02019; perception, views and satisfaction with pharmacists&#x02019; role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>20</volume><issue>4</issue><year>2012</year><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">23960807</pub-id>
</element-citation></ref><ref id="bb0535"><label>107</label><element-citation publication-type="journal" id="rf0535"><person-group person-group-type="author"><name><surname>Al-Tannir</surname><given-names>M.</given-names></name><name><surname>Alharbi</surname><given-names>A.I.</given-names></name><name><surname>Alfawaz</surname><given-names>A.S.</given-names></name><name><surname>Zahran</surname><given-names>R.I.</given-names></name><name><surname>AlTannir</surname><given-names>M.</given-names></name></person-group><article-title>Saudi adults satisfaction with community pharmacy services</article-title><source>Springerplus</source><volume>5</volume><issue>1</issue><year>2016</year><fpage>774</fpage><pub-id pub-id-type="pmid">27386260</pub-id>
</element-citation></ref><ref id="bb0540"><label>108</label><element-citation publication-type="journal" id="rf0540"><person-group person-group-type="author"><name><surname>Alhaddad</surname><given-names>M.S.</given-names></name><name><surname>Mudhish</surname><given-names>E.A.</given-names></name><name><surname>Bukhari</surname><given-names>R.A.</given-names></name><name><surname>Aladwani</surname><given-names>A.-A.A.</given-names></name><name><surname>Asiri</surname><given-names>S.M.</given-names></name></person-group><article-title>Assessment of female satisfaction with the role of male community pharmacists in the Kingdom of Saudi Arabia</article-title><source>J Clin Diagn Res</source><year>2018</year></element-citation></ref><ref id="bb0545"><label>109</label><element-citation publication-type="journal" id="rf0545"><person-group person-group-type="author"><name><surname>Alhaddad</surname><given-names>M.S.</given-names></name></person-group><article-title>Youth experience with community pharmacy services and their perceptions toward implementation of medication therapy management services by community pharmacists in the western region of Saudi Arabia</article-title><source>Ther Innov Regul Sci</source><volume>53</volume><issue>1</issue><year>2019</year><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">29714597</pub-id>
</element-citation></ref><ref id="bb0550"><label>110</label><element-citation publication-type="journal" id="rf0550"><person-group person-group-type="author"><name><surname>Al Juffali</surname><given-names>L.A.</given-names></name><name><surname>Knapp</surname><given-names>P.</given-names></name><name><surname>Al-Aqeel</surname><given-names>S.</given-names></name><name><surname>Watson</surname><given-names>M.C.</given-names></name></person-group><article-title>Medication safety problems priorities in community pharmacy in Saudi Arabia: a multi-stakeholder delphi study using the human factors framework</article-title><source>BMJ Open</source><volume>9</volume><issue>11</issue><year>2019</year><object-id pub-id-type="publisher-id">e032419</object-id></element-citation></ref><ref id="bb0555"><label>111</label><element-citation publication-type="journal" id="rf0555"><person-group person-group-type="author"><name><surname>Al Juffali</surname><given-names>L.</given-names></name><name><surname>Al-Aqeel</surname><given-names>S.</given-names></name><name><surname>Knapp</surname><given-names>P.</given-names></name><name><surname>Mearns</surname><given-names>K.</given-names></name><name><surname>Family</surname><given-names>H.</given-names></name><name><surname>Watson</surname><given-names>M.</given-names></name></person-group><article-title>Using the human factors framework to understand the origins of medication safety problems in community pharmacy: a qualitative study</article-title><source>Res Social Adm Pharm</source><volume>15</volume><issue>5</issue><year>2019</year><fpage>558</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">30031695</pub-id>
</element-citation></ref><ref id="bb0560"><label>112</label><element-citation publication-type="journal" id="rf0560"><person-group person-group-type="author"><name><surname>Mazhar</surname><given-names>F.</given-names></name><name><surname>Ahmed</surname><given-names>Y.</given-names></name><name><surname>Haider</surname><given-names>N.</given-names></name><name><surname>Al</surname><given-names>Ghamdi F.</given-names></name></person-group><article-title>Community pharmacist and primary care physician collaboration: the missing connection in pharmaceutical care</article-title><source>J Taibah Univ Med Sci</source><volume>12</volume><issue>3</issue><year>2017</year><fpage>273</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">31435251</pub-id>
</element-citation></ref><ref id="bb0565"><label>113</label><element-citation publication-type="journal" id="rf0565"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>Y.</given-names></name><name><surname>Imershein</surname><given-names>S.</given-names></name><name><surname>Maryniuk</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A program utilizing community pharmacists to improve diabetes education in the Kingdom of Saudi Arabia</article-title><source>Int J Pharm Pract</source><volume>28</volume><issue>1</issue><year>2020</year><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">31397513</pub-id>
</element-citation></ref><ref id="bb0570"><label>114</label><element-citation publication-type="journal" id="rf0570"><person-group person-group-type="author"><name><surname>Al-Rukban</surname><given-names>M.O.</given-names></name><name><surname>Khalil</surname><given-names>M.A.</given-names></name></person-group><article-title>Adherence to otc directory&#x02013;the perception of community pharmacists in Saudi Arabia</article-title><source>J Ayub Med Coll Abbottabad</source><volume>24</volume><issue>3&#x02013;4</issue><year>2012</year><fpage>43</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">24669606</pub-id>
</element-citation></ref><ref id="bb0575"><label>115</label><element-citation publication-type="journal" id="rf0575"><person-group person-group-type="author"><name><surname>Bawazir</surname><given-names>O.</given-names></name></person-group><article-title>Knowledge and attitudes of pharmacists regarding oral healthcare and oral hygiene products in Riyadh, Saudi Arabia</article-title><source>JIOH</source><volume>6</volume><issue>6</issue><year>2014</year><fpage>10</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">25628475</pub-id>
</element-citation></ref><ref id="bb0580"><label>116</label><element-citation publication-type="journal" id="rf0580"><person-group person-group-type="author"><name><surname>Alakhali</surname><given-names>K.M.</given-names></name></person-group><article-title>Assessment of self medication pattern of pharmacist in aseer region, Saudi Arabia</article-title><source>Bull Pharm Sci Ass</source><volume>39</volume><issue>1</issue><year>2016</year><fpage>87</fpage><lpage>93</lpage></element-citation></ref><ref id="bb0585"><label>117</label><element-citation publication-type="journal" id="rf0585"><person-group person-group-type="author"><name><surname>Al Rwisan</surname><given-names>A.A.</given-names></name><name><surname>Alshammari</surname><given-names>T.M.</given-names></name><name><surname>Tahir</surname><given-names>K.</given-names></name><name><surname>Aleissa</surname><given-names>F.</given-names></name><name><surname>Aljadhey</surname><given-names>H.</given-names></name></person-group><article-title>Community pharmacists&#x02019; knowledge of isotretinoin safety</article-title><source>Saudi Med J</source><volume>35</volume><issue>1</issue><year>2014</year><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">24445895</pub-id>
</element-citation></ref><ref id="bb0590"><label>118</label><element-citation publication-type="journal" id="rf0590"><person-group person-group-type="author"><name><surname>Alakhali</surname><given-names>K.M.</given-names></name></person-group><article-title>Attitudes and perceptions of community pharmacists to antibiotic dispensing and microbial resistance. A study in aseer region, Kingdom of Saudi Arabia</article-title><source>King Khalid Univ J Health Sci</source><volume>1</volume><issue>2</issue><year>2016</year><fpage>6</fpage></element-citation></ref><ref id="bb0595"><label>119</label><element-citation publication-type="journal" id="rf0595"><person-group person-group-type="author"><name><surname>Mahmoud</surname><given-names>M.A.</given-names></name><name><surname>Aldhaeefi</surname><given-names>M.</given-names></name><name><surname>Sheikh</surname><given-names>A.</given-names></name><name><surname>Aljadhey</surname><given-names>H.</given-names></name></person-group><article-title>Community pharmacists perspectives about reasons behind antibiotics dispensing without prescription: a qualitative study</article-title><source>Biomed Res</source><volume>29</volume><issue>21</issue><year>2018</year><fpage>3792</fpage><lpage>3796</lpage></element-citation></ref><ref id="bb0600"><label>120</label><element-citation publication-type="journal" id="rf0600"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>T.M.</given-names></name><name><surname>Azhar</surname><given-names>S.</given-names></name></person-group><article-title>A study investigating the community pharmacist knowledge about the appropriate use of inhaler, eastern region alahsa, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>21</volume><issue>2</issue><year>2013</year><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">23960829</pub-id>
</element-citation></ref><ref id="bb0605"><label>121</label><element-citation publication-type="journal" id="rf0605"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>21</volume><issue>4</issue><year>2013</year><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">24227954</pub-id>
</element-citation></ref><ref id="bb0610"><label>122</label><element-citation publication-type="journal" id="rf0610"><person-group person-group-type="author"><name><surname>Al-Arifi</surname><given-names>M.N.</given-names></name></person-group><article-title>Community pharmacist perception and attitude toward ethical issues at community pharmacy setting in Central Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>22</volume><issue>4</issue><year>2014</year><fpage>315</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">25161375</pub-id>
</element-citation></ref><ref id="bb0615"><label>123</label><element-citation publication-type="journal" id="rf0615"><person-group person-group-type="author"><name><surname>Almansour</surname><given-names>H.A.</given-names></name><name><surname>Aloudah</surname><given-names>N.M.</given-names></name><name><surname>Alhawassi</surname><given-names>T.M.</given-names></name><name><surname>Chaar</surname><given-names>B.</given-names></name><name><surname>Krass</surname><given-names>I.</given-names></name><name><surname>Saini</surname><given-names>B.</given-names></name></person-group><article-title>Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: a qualitative analysis</article-title><source>Saudi Pharm J</source><volume>28</volume><issue>5</issue><year>2020</year><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">32435133</pub-id>
</element-citation></ref><ref id="bb0620"><label>124</label><element-citation publication-type="journal" id="rf0620"><person-group person-group-type="author"><name><surname>Baracaldo-Santamar&#x000ed;a</surname><given-names>D.</given-names></name><name><surname>Trujillo-Moreno</surname><given-names>M.J.</given-names></name><name><surname>P&#x000e9;rez-Acosta</surname><given-names>A.M.</given-names></name><name><surname>Feliciano-Alfonso</surname><given-names>J.E.</given-names></name><name><surname>Calderon-Ospina</surname><given-names>C.A.</given-names></name><name><surname>Soler</surname><given-names>F.</given-names></name></person-group><article-title>Definition of self-medication: a scoping review</article-title><source>Ther Adv Drug Saf</source><volume>13</volume><year>2022</year><comment>20420986221127501</comment></element-citation></ref><ref id="bb0625"><label>125</label><element-citation publication-type="journal" id="rf0625"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>H.M.</given-names></name></person-group><article-title>Privacy level in private community pharmacies in Saudi Arabia: a simulated client survey</article-title><source>Pharmacol Pharm</source><volume>10</volume><issue>10</issue><year>2019</year><fpage>445</fpage></element-citation></ref><ref id="bb0630"><label>126</label><element-citation publication-type="journal" id="rf0630"><person-group person-group-type="author"><name><surname>Campeau Calfat</surname><given-names>A.</given-names></name><name><surname>Duval</surname><given-names>C.</given-names></name><name><surname>Laberge</surname><given-names>M.</given-names></name><name><surname>Savard</surname><given-names>A.-M.</given-names></name><name><surname>Sirois</surname><given-names>C.</given-names></name></person-group><article-title>Clinical services in community pharmacies: a scoping review of policy and social implications</article-title><source>Int J Pharm Pract</source><volume>29</volume><issue>2</issue><year>2020</year><fpage>116</fpage><lpage>125</lpage></element-citation></ref><ref id="bb0635"><label>127</label><element-citation publication-type="journal" id="rf0635"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>A.S.</given-names></name><name><surname>Benrimoj</surname><given-names>S.I.</given-names></name><name><surname>Chen</surname><given-names>T.F.</given-names></name><name><surname>Williams</surname><given-names>K.A.</given-names></name><name><surname>Aslani</surname><given-names>P.</given-names></name></person-group><article-title>Implementing cognitive services in community pharmacy: a review of models and frameworks for change</article-title><source>Int J Pharm Pract</source><volume>14</volume><issue>2</issue><year>2010</year><fpage>105</fpage><lpage>113</lpage></element-citation></ref><ref id="bb0640"><label>128</label><element-citation publication-type="journal" id="rf0640"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>F.R.</given-names></name><name><surname>Hor</surname><given-names>S.-Y.</given-names></name><name><surname>Bajorek</surname><given-names>B.V.</given-names></name></person-group><article-title>Considerations of australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study</article-title><source>BMC Health Serv Res</source><volume>21</volume><issue>1</issue><year>2021</year><fpage>906</fpage><pub-id pub-id-type="pmid">34479542</pub-id>
</element-citation></ref><ref id="bb0645"><label>129</label><element-citation publication-type="journal" id="rf0645"><person-group person-group-type="author"><name><surname>Naseralallah</surname><given-names>L.</given-names></name><name><surname>Stewart</surname><given-names>D.</given-names></name><name><surname>Price</surname><given-names>M.</given-names></name><name><surname>Paudyal</surname><given-names>V.</given-names></name></person-group><article-title>Prevalence, contributing factors, and interventions to reduce medication errors in outpatient and ambulatory settings: a systematic review</article-title><source>Int J Clin Pharmacol</source><volume>45</volume><issue>6</issue><year>2023</year><fpage>1359</fpage><lpage>1377</lpage></element-citation></ref><ref id="bb0650"><label>130</label><element-citation publication-type="book" id="rf0650"><person-group person-group-type="editor"><name><surname>Donaldson</surname><given-names>L.R.W.</given-names></name><name><surname>Sheridan</surname><given-names>S.</given-names></name><etal/></person-group><source>Textbook of Patient Safety and Clinical Risk Management</source><year>2021</year><publisher-name>Springer</publisher-name><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK585609/" id="ir0045">https://www.ncbi.nlm.nih.gov/books/NBK585609/</ext-link></element-citation></ref><ref id="bb0655"><label>131</label><element-citation publication-type="journal" id="rf0655"><person-group person-group-type="author"><name><surname>Bin Yousef</surname><given-names>N.</given-names></name><name><surname>Yenugadhati</surname><given-names>N.</given-names></name><name><surname>Alqahtani</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Patterns of adverse drug reactions (adrs) in Saudi Arabia</article-title><source>Saudi Pharm J</source><volume>30</volume><issue>1</issue><year>2022</year><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">35145342</pub-id>
</element-citation></ref><ref id="bb0660"><label>132</label><element-citation publication-type="journal" id="rf0660"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>K.S.</given-names></name><name><surname>Petzold</surname><given-names>M.</given-names></name><name><surname>Alsugoor</surname><given-names>M.H.</given-names></name><name><surname>Makeen</surname><given-names>H.A.</given-names></name><name><surname>Al Monif</surname><given-names>K.H.</given-names></name><name><surname>Hussain-Alkhateeb</surname><given-names>L.</given-names></name></person-group><article-title>Community pharmacists&#x02019; perspectives towards automated pharmacy systems and extended community pharmacy services: an online cross-sectional study</article-title><source>Explor Res Clin Soc Pharm</source><volume>12</volume><year>2023</year><object-id pub-id-type="publisher-id">100363</object-id></element-citation></ref><ref id="bb0665"><label>133.</label><element-citation publication-type="other" id="rf0665"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Healthcare Licensing Services</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sa/en/eServices/Licences/Pages/Licences.aspx" id="ir0050">https://www.moh.gov.sa/en/eServices/Licences/Pages/Licences.aspx</ext-link><year>2023</year></element-citation></ref><ref id="bb0670"><label>134.</label><element-citation publication-type="other" id="rf0670"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Healthcare Licensing Services</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sa/eServices/Licences/Documents/113.pdf" id="ir0055">https://www.moh.gov.sa/eServices/Licences/Documents/113.pdf</ext-link><year>2024</year></element-citation></ref><ref id="bb0675"><label>135.</label><element-citation publication-type="other" id="rf0675"><person-group person-group-type="author"><name><surname>Saudi MOH</surname></name></person-group><article-title>Healthcare Licensing Services</article-title><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sa/eServices/Licences/Documents/113.pdf" id="ir0060">https://www.moh.gov.sa/eServices/Licences/Documents/113.pdf</ext-link><year>2024</year></element-citation></ref><ref id="bb0680"><label>136</label><element-citation publication-type="journal" id="rf0680"><person-group person-group-type="author"><name><surname>Suleiman</surname><given-names>A.</given-names></name></person-group><article-title>Stress and job satisfaction among pharmacists in Riyadh, Saudi Arabia</article-title><source>Saudi J Med Med Sci</source><volume>3</volume><issue>3</issue><year>2015</year></element-citation></ref><ref id="bb0685"><label>137</label><element-citation publication-type="journal" id="rf0685"><person-group person-group-type="author"><name><surname>Alghamdi</surname><given-names>K.S.</given-names></name><name><surname>Alsugoor</surname><given-names>M.H.</given-names></name><name><surname>Petzold</surname><given-names>M.</given-names></name><name><surname>Hussain-Alkhateeb</surname><given-names>L.</given-names></name><name><surname>Ljungberg</surname><given-names>Persson C.</given-names></name></person-group><article-title>Multi-stakeholder perspectives of community pharmacies&#x02019; extended services in al baha province, Saudi Arabia: a qualitative study</article-title><source>Glob Public Health</source><volume>20</volume><issue>1</issue><year>2025</year><fpage>2452218</fpage><pub-id pub-id-type="pmid">39815197</pub-id>
</element-citation></ref><ref id="bb0690"><label>138</label><element-citation publication-type="journal" id="rf0690"><person-group person-group-type="author"><name><surname>Alhusein</surname><given-names>N.</given-names></name><name><surname>Watson</surname><given-names>M.C.</given-names></name></person-group><article-title>Quality indicators and community pharmacy services: a scoping review</article-title><source>Int J Pharm Pract</source><volume>27</volume><issue>6</issue><year>2019</year><fpage>490</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">31264751</pub-id>
</element-citation></ref><ref id="bb0695"><label>139.</label><element-citation publication-type="book" id="rf0695"><person-group person-group-type="author"><name><surname>FIP</surname></name></person-group><part-title>Global competency framework: Supporting early career training strategy</part-title><year>2021</year><comment>[accessed 8 March 2025]</comment><ext-link ext-link-type="uri" xlink:href="https://www.fip.org/file/5546" id="ir0065">https://www.fip.org/file/5546</ext-link></element-citation></ref><ref id="bb0700"><label>140</label><element-citation publication-type="journal" id="rf0700"><person-group person-group-type="author"><name><surname>Molina-Azorin</surname><given-names>J.F.</given-names></name></person-group><article-title>Mixed methods research: an opportunity to improve our studies and our research skills</article-title><source>Eur J Manag Bus Econ</source><volume>25</volume><issue>2</issue><year>2016</year><fpage>37</fpage><lpage>38</lpage></element-citation></ref><ref id="bb0705"><label>141.</label><mixed-citation publication-type="other" id="or0005">Pollock M FR, Becker LA, Pieper D, Hartling L. Chapter 5: Overviews of reviews. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor. Cochrane Handbook for Systematic Reviews of Interventions. [accessed 8 March 2025]. <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook/current/chapter-v" id="ir0070">https://training.cochrane.org/handbook/current/chapter-v</ext-link>.</mixed-citation></ref><ref id="bb0710"><label>142.</label><mixed-citation publication-type="other" id="or0010">McKenzie JE BS, Ryan RE, Thomson HJ, Johnston RV, Thomas J. Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor. Cochrane Handbook for Systematic Reviews of Interventions [accessed 8 March 2025]. <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook/current/chapter-03" id="ir0075">https://training.cochrane.org/handbook/current/chapter-03</ext-link>.</mixed-citation></ref><ref id="bb0715"><label>143.</label><mixed-citation publication-type="other" id="or0015">Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., &#x00026; Welch, V. A. Chapter 10: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic reviews of Interventions. [accessed 8 March 2025]. <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook/archive/v6.4/chapter-10#section-10-11-5-1" id="ir0080">https://training.cochrane.org/handbook/archive/v6.4/chapter-10#section-10-11-5-1</ext-link>.</mixed-citation></ref><ref id="bb0720"><label>144</label><element-citation publication-type="journal" id="rf0705"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>T.H.</given-names></name><name><surname>Migliavaca</surname><given-names>C.B.</given-names></name><name><surname>Stein</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence</article-title><source>BMC Med Res Methodol</source><volume>21</volume><issue>1</issue><year>2021</year><fpage>189</fpage><pub-id pub-id-type="pmid">34544368</pub-id>
</element-citation></ref></ref-list></back></article>